Citrus Sinensis ID: 037230


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-----
MKVHETRSHAHASSDEEKVMTRKQKAENKTQEATETPPKKTKQENNGNGGHANGKRSGDVTAEFEEFCKSIEGQLSAEQMREILELNGQDSSGSDVAVVTKCLDMLFYGPLDKCPVCNGNLEFDGKRYSCKGMYSEWSTCTFRTKDPPRKQEPTKLPDSVLNSPISDLAKRYQDPSHRPRRDVGAAVKPFTGMTISLMGRLSRTHQYWRTTIEKHGGKVAASPIGLTCLVASPAERERGGSSKLVEAMERGTRVVSEAWLIDSIEKQEAQPLEAYDLVTDLAPDSKGIPWDKMDPSEEAIESIAAELKLYGKRGVYKDTKLQEQGGKILEKDGILYNCAFSLCDQGRGMNLYCIVQLITVPDSNLHLYYKKGKVGDDPNAEERLEEWTGVDNAIKEFVRLFEEVTGNEFEPWEREKKFQKKPLKFYPIDMDDGVEVRHGGLGMRQLGVAAAHSKLDPVVANFMKVLCSQEVYRYALMEMGLDAPDLPIGMLSNVHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLMHSLRPFIFRDNQEIADHAASSFEAVRDITVASHLIGDMSGSTLDDPLSDCYEKLACSISALEKDSDDYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNAQPSLDEIKKLPNKVLLWCGTRSSNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLVLAVASLGDQVTELKKPPEDTKSLEDKKLGVKGLGRKKTDESEHFFWNDDIKVPGGRLIPSEHKNSPLEYNEYAVYDPKQTSIRFLVGVKFEERGVEMEPAE
ccccccccccccccHHHHHHHHHHHHHccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHccHHHHHHHHHHccccccccHHHHHHHHHHHHHccccccccccccEEEEEccEEEEEcccccccEEcccccccccccccccccccccccccHHHHHccccccccccccccccccccccEEEEEEccccccHHHHHHHHHHcccEEEEEccccEEEEEccHHHHccccHHHHHHHHHcccEEEHHHHHHHHHHHcccccccccccccccccccccccccccccHHHHHHHHHHHHHcccccccccccccccccccccccccccccEEEEcccccccccEEEEEEEEEccccEEEEEEEccccccccccccccccccHHHHHHHHHHHHHHHHccccccccccccccccccccEEEEcccccHHccccccccccccccccccccHHHHHHHHHHccHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHcHHHHHHHHcccccccccccHHHHHHHcccEEEEcccccHHHHHHHHHHHHccccccccccEEccEEEEEEEEcccccccccHHcccccEEEEEcccccccHHHHHccccccccccccccccccccEEEEcccHHHHHccccccccccEEEEEEEEEEccccccccccccccccccccccccEEEEccccccccccEEEcccEEEccccccccccccccccccEEEEEcccccEEEEEEEEEEEcccccccccc
ccccccccHHHHHcHHHHHHHHHHccHHcccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHccccccccHHHHHHHHHHHHHHcccccccccccEEEEEccEEEEEEEEEEcEEEEEEcccccccccccEccHHHcHHHHHHHHHHccccccccccccccccccccccEEEEEEcccccHHHHHHHHHHcccEEEEEEcccEEEEEEcHHHHHcccHHHHHHHHccccEEcHHHHHHHHHccccccHHHcccccccccccccccccccccccccccccEEEEEEccccccccccccccccEEEEEcccEEEEEEEEEEEcccccccEEEEEEEEcccccEEEEEEccccccEccccccccccccHHHHHHHHHHHHHHHcccccccHHHccccccccccEEEEEEEcccccccccccccccccccccccccHHHHHHHHHHHcHHHHHHHHHHHcccHccccccHccHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHccHEEEcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHHHHHccccccEcccccHHHHHHHHHHHHcccccccccccEEEEEEEEEEEEcccccHcccHHHcccEEEEEEEccHHHHHHHHHHccccccccccHHHccccccEEEEccHHHHHHHHcccccccEEEEEEEEEEcccHHHHHHcccccHccccccccEEEccccccccccccEEccccEEEccccccccccccccEEEcEEEEEcHHHEEEEEEEEEEEEcccEEEEccc
mkvhetrshahassdeEKVMTRKQKAEnktqeatetppkktkqenngngghangkrsgdvTAEFEEFCKSIEGQLSAEQMREILELngqdssgsdVAVVTKCLdmlfygpldkcpvcngnlefdgkrysckgmysewstctfrtkdpprkqeptklpdsvlnspisdlakryqdpshrprrdvgaavkpftGMTISLMGRLSRTHQYWRTTIEkhggkvaaspigltclvaspaererggssKLVEAMERGTRVVSEAWLIDSIEkqeaqpleaYDLVtdlapdskgipwdkmdpseEAIESIAAELKLYGkrgvykdtklqeqggkilekdgilyncafslcdqgrgmnlYCIVQLItvpdsnlhlyykkgkvgddpnaeERLEEWTGVDNAIKEFVRLFEEvtgnefepwerekkfqkkplkfypidmddgvevrhgglgmrQLGVaaahskldPVVANFMKVLCSQEVYRYALMEmgldapdlpigmlsnvHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLMhslrpfifrdnqEIADHAASSFEAVRDITVASHLigdmsgstlddplsdCYEKLACSISALEKDSDDYKMIVNYLEKtyepvklgdieygvsvDNIFVIesnaqpsldeikklpnkvLLWCGTRSSNLLRHLQkgflpascslpvpgymfgRAIVCSDAAAEAARYgftaadrpEGFLVLAVASLGdqvtelkkppedtksledkklgvkglgrkktdesehffwnddikvpggrlipsehknspleyneyavydpkqtsIRFLVGVkfeergvemepae
mkvhetrshahassdeekvmTRKQKaenktqeatetppkktkqenngngghangkrsGDVTAEFEEFCKSIEGQLSAEQMREILELngqdssgsDVAVVTKCLDMLFYGPLDKCPVCNGNLEFDGKRYSCKGMYSEWStctfrtkdpprkqeptklpdsvlnspiSDLAkryqdpshrprrdvgaavkpfTGMTISLMGRLSRTHQYWRTTIEKhggkvaaspiGLTCLVaspaererggssklveamERGTRVVSEAWLIDSIEKQEAQPLEAYDLVTDLAPDSKGIPWDKMDPSEEAIESIAAELKLYGKRgvykdtklqeqggkilekdgiLYNCAFSLCDQGRGMNLYCIVQLITVPDSNLHLYYKKGKVGDDPNAEERLEEWTGVDNAIKEFVRLFEEvtgnefepwerekkfqkkplkfypidmdDGVEVRHGGLGMRQLGVAAAHSKLDPVVANFMKVLCSQEVYRYALMEMGLDAPDLPIGMLSNVHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLMHSLRPFIFRDNQEIADHAASSFEAVRDITVASHLIGDMSGSTLDDPLSDCYEKLACSIsalekdsddYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNAQPSLDEIKKLPNKVLLWCGTRSSNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLVLAVASLGdqvtelkkppedtksledkklgvkglgrkktdesehffwnddikvpggrlIPSEHKNSPLEYNEyavydpkqtSIRFLVGVKFEergvemepae
MKVHETRSHAHASSDEEKVMTRKQKAENKTQEATETPPKKTKQENNGNGGHANGKRSGDVTAEFEEFCKSIEGQLSAEQMREILELNGQDSSGSDVAVVTKCLDMLFYGPLDKCPVCNGNLEFDGKRYSCKGMYSEWSTCTFRTKDPPRKQEPTKLPDSVLNSPISDLAKRYQDPSHRPRRDVGAAVKPFTGMTISLMGRLSRTHQYWRTTIEKHGGKVAASPIGLTCLVASPAERERGGSSKLVEAMERGTRVVSEAWLIDSIEKQEAQPLEAYDLVTDLAPDSKGIPWDKMDPseeaiesiaaeLKLYGKRGVYKDTKLQEQGGKILEKDGILYNCAFSLCDQGRGMNLYCIVQLITVPDSNLHLYYKKGKVGDDPNAEERLEEWTGVDNAIKEFVRLFEEVTGNEFEPWEREKKFQKKPLKFYPIDMDDGVEVRHGGLGMRQLGVAAAHSKLDPVVANFMKVLCSQEVYRYALMEMGLDAPDLPIGMLSNVHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLMHSLRPFIFRDNQEIADHAASSFEAVRDITVASHLIGDMSGSTLDDPLSDCYEKLACSISALEKDSDDYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNAQPSLDEIKKLPNKVLLWCGTRSSNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLVLAVASLGDQVTELKKPPEDTKSLEDkklgvkglgrkkTDESEHFFWNDDIKVPGGRLIPSEHKNSPLEYNEYAVYDPKQTSIRFLVGVKFEERGVEMEPAE
**********************************************************************************************DVAVVTKCLDMLFYGPLDKCPVCNGNLEFDGKRYSCKGMYSEWSTCTFR*****************************************AAVKPFTGMTISLMGRLSRTHQYWRTTIEKHGGKVAASPIGLTCLVA********************TRVVSEAWLIDSIEKQEAQPLEAYDLVTDLA*****************IESIAAELKLYGKRGVYKDTKLQEQGGKILEKDGILYNCAFSLCDQGRGMNLYCIVQLITVPDSNLHLYYKKGKVGD*****ERLEEWTGVDNAIKEFVRLFEEVTGNEFEPWEREKKFQKKPLKFYPIDMDDGVEVRHGGLGMRQLGVAAAHSKLDPVVANFMKVLCSQEVYRYALMEMGLDAPDLPIGMLSNVHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLMHSLRPFIFRDNQEIADHAASSFEAVRDITVASHLIGDMSGSTLDDPLSDCYEKLACSISALEKDSDDYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNAQPSLDEIKKLPNKVLLWCGTRSSNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLVLAVASLGD**********************************HFFWNDDIKVPGGRLI********LEYNEYAVYDPKQTSIRFLVGVKF***********
**************************************************************EFEEFCKSIEGQLSAEQMREILELNGQDSSGSDVAVVTKCLDMLFYGPLDKCPVCNGNLEFDGKRYSCKGMYSEWSTCTFRTKDPP*****TKLPDSVLNSPISDLA********************FTGMTISLMGRLSRTHQYWRTTIEKHGGKVAASPIGLTCLVASPAER***********MERGTRVVSEAWLIDSIEKQEAQPLEAYDLVTDLAPDSKGIPWDKMDPSEEAIESIAAELKLYGKRGVYKDTKLQEQGGKILEKDGILYNCAFSLCDQGRGMNLYCIVQLITVPDSNLHLYYKKGKVGDDPNAEERLEEWTGVDNAIKEFVRLFEEVTGNEFEPWEREKKFQKKPLKFYPIDMDDGVEVRHGGL************KLDPVVANFMKVLCSQEVYRYALMEMGLDAPDLPIGMLSNVHLNRCEEVLQQFIE***************WTDFSNRWFTLMHSLRPFIFRDNQEIADHAASSFEAVRDITVASHLIGDMS*STLDDPLSDCYEKLACSISALEKDSDDYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNAQPSLDEIKKLPNKVLLWCGTRSSNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLVLAVASLGDQVTELKKPPEDT*SLEDKKLGVKGLGRKKTDESEHFFWNDDIKVPGGRLIPSEHKNSPLEYNEYAVYDPKQTSIRFLVGVKFEER********
***********************************************NGGHANGKRSGDVTAEFEEFCKSIEGQLSAEQMREILELNGQDSSGSDVAVVTKCLDMLFYGPLDKCPVCNGNLEFDGKRYSCKGMYSEWSTCTFRT************PDSVLNSPISDLAK**********RDVGAAVKPFTGMTISLMGRLSRTHQYWRTTIEKHGGKVAASPIGLTCLVASPAERERGGSSKLVEAMERGTRVVSEAWLIDSIEKQEAQPLEAYDLVTDLAPDSKGIPWDKMDPSEEAIESIAAELKLYGKRGVYKDTKLQEQGGKILEKDGILYNCAFSLCDQGRGMNLYCIVQLITVPDSNLHLYYKKGKVGDDPNAEERLEEWTGVDNAIKEFVRLFEEVTGNEFEPWEREKKFQKKPLKFYPIDMDDGVEVRHGGLGMRQLGVAAAHSKLDPVVANFMKVLCSQEVYRYALMEMGLDAPDLPIGMLSNVHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLMHSLRPFIFRDNQEIADHAASSFEAVRDITVASHLIGDMSGSTLDDPLSDCYEKLACSISALEKDSDDYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNAQPSLDEIKKLPNKVLLWCGTRSSNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLVLAVASLGDQVTELKKPPEDTKSLEDKKLGVKGLGRKKTDESEHFFWNDDIKVPGGRLIPSEHKNSPLEYNEYAVYDPKQTSIRFLVGVKFEER********
**************************************************HANGKRSGDVTAEFEEFCKSIEGQLSAEQMREILELNGQDSSGSDVAVVTKCLDMLFYGPLDKCPVCNGNLEFDGKRYSCKGMYSEWSTCTFRTKDPPRKQEPTKLPDSVLNSPISDLAKRYQ**************KPFTGMTISLMGRLSRTHQYWRTTIEKHGGKVAASPIGLTCLVASPAERERGGSSKLVEAMERGTRVVSEAWLIDSIEKQ**********************************SIAAELKLYGKRGVYKDTKLQEQGGKILEKDGILYNCAFSLCDQGRGMNLYCIVQLITVPDSNLHLYYKKGKVGDDPNAEERLEEWTGVDNAIKEFVRLFEEVTGNEFEPWEREKKFQKKPLKFYPIDMDDGVE****************HSKLDPVVANFMKVLCSQEVYRYALMEMGLDAPDLPIGMLSNVHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLMHSLRPFIFRDNQEIADHAASSFEAVRDITVASHLIGDMSGSTLDDPLSDCYEKLACSISALEKDSDDYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNAQPSLDEIKKLPNKVLLWCGTRSSNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLVLAVASLGDQVTELKKPPEDTKSLEDKKLGVKGLGRKKTDESEHFFWNDDIKVPGGRLIPSEHKNSPLEYNEYAVYDPKQTSIRFLVGVKFEERGVEMEP**
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiii
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MKVHETRSHAHASSDEEKVMTRKQKAENKTQEATETPPKKTKQENNGNGGHANGKRSGDVTAEFEEFCKSIEGQLSAEQMREILELNGQDSSGSDVAVVTKCLDMLFYGPLDKCPVCNGNLEFDGKRYSCKGMYSEWSTCTFRTKDPPRKQEPTKLPDSVLNSPISDLAKRYQDPSHRPRRDVGAAVKPFTGMTISLMGRLSRTHQYWRTTIEKHGGKVAASPIGLTCLVASPAERERGGSSKLVEAMERGTRVVSEAWLIDSIEKQEAQPLEAYDLVTDLAPDSKGIPWDKMDPSEEAIESIAAELKLYGKRGVYKDTKLQEQGGKILEKDGILYNCAFSLCDQGRGMNLYCIVQLITVPDSNLHLYYKKGKVGDDPNAEERLEEWTGVDNAIKEFVRLFEEVTGNEFEPWEREKKFQKKPLKFYPIDMDDGVEVRHGGLGMRQLGVAAAHSKLDPVVANFMKVLCSQEVYRYALMEMGLDAPDLPIGMLSNVHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLMHSLRPFIFRDNQEIADHAASSFEAVRDITVASHLIGDMSGSTLDDPLSDCYEKLACSISALEKDSDDYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNAQPSLDEIKKLPNKVLLWCGTRSSNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLVLAVASLGDQVTELKKPPEDTKSLEDKKLGVKGLGRKKTDESEHFFWNDDIKVPGGRLIPSEHKNSPLEYNEYAVYDPKQTSIRFLVGVKFEERGVEMEPAE
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query815 2.2.26 [Sep-21-2011]
Q9SWB4815 Poly [ADP-ribose] polymer yes no 0.986 0.986 0.754 0.0
Q1SGF1799 Putative poly [ADP-ribose N/A no 0.977 0.997 0.731 0.0
Q9FK91814 Poly [ADP-ribose] polymer yes no 0.990 0.991 0.713 0.0
Q0E0Q3831 Poly [ADP-ribose] polymer yes no 0.995 0.975 0.592 0.0
Q9ZP54983 Poly [ADP-ribose] polymer no no 0.861 0.714 0.32 1e-100
Q7EYV7977 Poly [ADP-ribose] polymer no no 0.856 0.714 0.302 4e-97
Q9ZSV1980 Poly [ADP-ribose] polymer N/A no 0.855 0.711 0.293 3e-92
P098741014 Poly [ADP-ribose] polymer yes no 0.865 0.695 0.283 3e-69
Q9R1521013 Poly [ADP-ribose] polymer yes no 0.866 0.696 0.283 1e-68
P184931016 Poly [ADP-ribose] polymer yes no 0.865 0.693 0.285 2e-68
>sp|Q9SWB4|PARP3_SOYBN Poly [ADP-ribose] polymerase 3 OS=Glycine max GN=PARP3 PE=2 SV=1 Back     alignment and function desciption
 Score = 1301 bits (3366), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 609/807 (75%), Positives = 695/807 (86%), Gaps = 3/807 (0%)

Query: 1   MKVHETRSHAHASSDEEKVMTRKQKAENKTQEATETPPKKTKQENNGNGGHANGKRSGDV 60
           MKV ETRSH HA  +EEKVMTRKQKAE+K  E  E  PKK K E     GH NGK    V
Sbjct: 1   MKVQETRSHVHALGEEEKVMTRKQKAESKAHE-VEHSPKKAKVEKED--GHINGKSETGV 57

Query: 61  TAEFEEFCKSIEGQLSAEQMREILELNGQDSSGSDVAVVTKCLDMLFYGPLDKCPVCNGN 120
             E++EFCK+    L  EQMR+ILE NG DSSGSD+ +  +C D+LFYG LDKC VCNG+
Sbjct: 58  AEEYDEFCKATTEHLPLEQMRDILEANGLDSSGSDLEITRRCQDLLFYGALDKCSVCNGS 117

Query: 121 LEFDGKRYSCKGMYSEWSTCTFRTKDPPRKQEPTKLPDSVLNSPISDLAKRYQDPSHRPR 180
           LEFDG+RY C+G YSEW++CTF T++PPRKQEP KLPDSV NS  SDL K+YQDPSHRP 
Sbjct: 118 LEFDGRRYVCRGFYSEWASCTFSTRNPPRKQEPIKLPDSVQNSLASDLLKKYQDPSHRPH 177

Query: 181 RDVGAAVKPFTGMTISLMGRLSRTHQYWRTTIEKHGGKVAASPIGLTCLVASPAERERGG 240
           RD+G A KPFTGM ISLMGRL+RTH YW+TTIEKHGGKVA S IG TCLVASPAERERGG
Sbjct: 178 RDLGLAEKPFTGMMISLMGRLTRTHHYWKTTIEKHGGKVANSIIGSTCLVASPAERERGG 237

Query: 241 SSKLVEAMERGTRVVSEAWLIDSIEKQEAQPLEAYDLVTDLAPDSKGIPWDKMDPSEEAI 300
           +SKL EAMER   VV EAWLIDSIEKQE QPLEAYDLV+DL+ D KGIPWDK DP EEAI
Sbjct: 238 TSKLAEAMERSIPVVREAWLIDSIEKQEPQPLEAYDLVSDLSVDGKGIPWDKQDPGEEAI 297

Query: 301 ESIAAELKLYGKRGVYKDTKLQEQGGKILEKDGILYNCAFSLCDQGRGMNLYCIVQLITV 360
           ES++AELKLYGKRGVYKDTKLQEQGGKI E+DGILYNCAFS+CDQGRG+N YC++QLI V
Sbjct: 298 ESLSAELKLYGKRGVYKDTKLQEQGGKIFERDGILYNCAFSVCDQGRGLNDYCVMQLIVV 357

Query: 361 PDSNLHLYYKKGKVGDDPNAEERLEEWTGVDNAIKEFVRLFEEVTGNEFEPWEREKKFQK 420
           P++ LHLY+KKG+VGDDPNAEERLEEW  VD A+KEFVRLFEE+TGNEFEPWEREKKFQK
Sbjct: 358 PENRLHLYFKKGRVGDDPNAEERLEEWDNVDGALKEFVRLFEEITGNEFEPWEREKKFQK 417

Query: 421 KPLKFYPIDMDDGVEVRHGGLGMRQLGVAAAHSKLDPVVANFMKVLCSQEVYRYALMEMG 480
           KPLKFYPIDMDDG+EVRHG LG+RQLG+AA H KL+P+VANFMKVLCSQE+Y+YALMEMG
Sbjct: 418 KPLKFYPIDMDDGIEVRHGALGLRQLGIAATHCKLEPLVANFMKVLCSQEIYKYALMEMG 477

Query: 481 LDAPDLPIGMLSNVHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLMHSLRP 540
            D PDLPIGM++N+HL +CE+VL +FI+ VKS KETG KAEA+WTDFS RWFTLMHS RP
Sbjct: 478 YDCPDLPIGMVTNLHLKKCEDVLLEFIDKVKSLKETGPKAEAVWTDFSQRWFTLMHSTRP 537

Query: 541 FIFRDNQEIADHAASSFEAVRDITVASHLIGDMSGSTLDDPLSDCYEKLACSISALEKDS 600
           F FRD QEIADHAA++ E VRDIT ASHLIGDM+GST+DDPLS+ Y+KL CSISAL+K S
Sbjct: 538 FNFRDYQEIADHAAAALEGVRDITQASHLIGDMTGSTIDDPLSETYKKLGCSISALDKSS 597

Query: 601 DDYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNAQPSLDEIKKLPNKVLLWCGTRS 660
           DDY+MIV YLEKTYEPVK+GDIEYGVSV+NIF +++   PS ++I KLPNKVLLWCG+RS
Sbjct: 598 DDYEMIVKYLEKTYEPVKVGDIEYGVSVENIFAVQTGGCPSYEDIIKLPNKVLLWCGSRS 657

Query: 661 SNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLVLAVASL 720
           SNLLRHLQKGFLPA CSLP+PGYMFG+AIVCSDAAAEAARYGFTA DRPEGFLVLA+ASL
Sbjct: 658 SNLLRHLQKGFLPAICSLPIPGYMFGKAIVCSDAAAEAARYGFTAVDRPEGFLVLAIASL 717

Query: 721 GDQVTELKKPPEDTKSLEDKKLGVKGLGRKKTDESEHFFWNDDIKVPGGRLIPSEHKNSP 780
           G+++TELK PPED  SLE+KK+GVKG G+KKTDESEHF W DDIKVP G+L+ S+H++SP
Sbjct: 718 GNEITELKTPPEDASSLEEKKVGVKGPGKKKTDESEHFVWKDDIKVPCGKLVASDHQDSP 777

Query: 781 LEYNEYAVYDPKQTSIRFLVGVKFEER 807
           LEYNEYAVYD K+  I +LVGVK+EE+
Sbjct: 778 LEYNEYAVYDKKRARISYLVGVKYEEK 804




Involved in the base excision repair (BER) pathway, by catalyzing the poly(ADP-ribosyl)ation of a limited number of acceptor proteins involved in chromatin architecture and in DNA metabolism. This modification follows DNA damages and appears as an obligatory step in a detection/signaling pathway leading to the reparation of DNA strand breaks.
Glycine max (taxid: 3847)
EC: 2EC: .EC: 4EC: .EC: 2EC: .EC: 3EC: 0
>sp|Q1SGF1|PARP3_MEDTR Putative poly [ADP-ribose] polymerase 3 OS=Medicago truncatula GN=PARP3 PE=3 SV=1 Back     alignment and function description
>sp|Q9FK91|PARP3_ARATH Poly [ADP-ribose] polymerase 3 OS=Arabidopsis thaliana GN=PARP3 PE=2 SV=2 Back     alignment and function description
>sp|Q0E0Q3|PARP3_ORYSJ Poly [ADP-ribose] polymerase 3 OS=Oryza sativa subsp. japonica GN=PARP3 PE=2 SV=1 Back     alignment and function description
>sp|Q9ZP54|PARP1_ARATH Poly [ADP-ribose] polymerase 1 OS=Arabidopsis thaliana GN=PARP1 PE=1 SV=2 Back     alignment and function description
>sp|Q7EYV7|PARP1_ORYSJ Poly [ADP-ribose] polymerase 1 OS=Oryza sativa subsp. japonica GN=PARP1 PE=2 SV=1 Back     alignment and function description
>sp|Q9ZSV1|PARP1_MAIZE Poly [ADP-ribose] polymerase 1 OS=Zea mays GN=PARP1 PE=2 SV=1 Back     alignment and function description
>sp|P09874|PARP1_HUMAN Poly [ADP-ribose] polymerase 1 OS=Homo sapiens GN=PARP1 PE=1 SV=4 Back     alignment and function description
>sp|Q9R152|PARP1_CRIGR Poly [ADP-ribose] polymerase 1 OS=Cricetulus griseus GN=PARP1 PE=2 SV=3 Back     alignment and function description
>sp|P18493|PARP1_BOVIN Poly [ADP-ribose] polymerase 1 OS=Bos taurus GN=PARP1 PE=2 SV=2 Back     alignment and function description

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query815
TAIR|locus:2171137814 AT5G22470 [Arabidopsis thalian 0.995 0.996 0.686 1.80000001999e-316
TAIR|locus:2042511983 PARP1 "POLY(ADP-RIBOSE) POLYME 0.797 0.661 0.300 8.1e-76
UNIPROTKB|P098741014 PARP1 "Poly [ADP-ribose] polym 0.733 0.589 0.286 1.1e-62
UNIPROTKB|P184931016 PARP1 "Poly [ADP-ribose] polym 0.734 0.589 0.287 3.5e-62
UNIPROTKB|F1MU081016 PARP1 "Poly [ADP-ribose] polym 0.734 0.589 0.286 9.1e-62
UNIPROTKB|J9NXE3972 PARP1 "Uncharacterized protein 0.730 0.612 0.288 2.3e-60
UNIPROTKB|F1Q2M3976 PARP1 "Uncharacterized protein 0.728 0.608 0.293 3.6e-60
ZFIN|ZDB-GENE-030131-39551013 parp1 "poly (ADP-ribose) polym 0.732 0.589 0.265 4.2e-60
RGD|20531014 Parp1 "poly (ADP-ribose) polym 0.732 0.588 0.283 4.4e-60
UNIPROTKB|I3LDH31018 PARP1 "Uncharacterized protein 0.728 0.583 0.287 1.8e-59
TAIR|locus:2171137 AT5G22470 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
 Score = 3035 (1073.4 bits), Expect = 1.8e-316, P = 1.8e-316
 Identities = 560/816 (68%), Positives = 662/816 (81%)

Query:     1 MKVHETRSHAHASSDEEKVMTRKQKAENKTQEATETPPKKTKQENNGNGGHANGKRSGDV 60
             MKVHETRSHAH S DE+K   RK KAE K  E+ E   KK K EN+ +G   NG  +GD 
Sbjct:     1 MKVHETRSHAHMSGDEQKGNLRKHKAEGKLPES-EQSQKKAKPEND-DGRSVNG--AGDA 56

Query:    61 TAEFEEFCKSIEGQLSAEQMREILELNGQDSSGSDVAVVTKCLDMLFYGPLDKCPVCNGN 120
              +E+ EFCK++E  LS +Q++E+LE+NGQD S  +  ++ +C D+LFYG L KCP+C G 
Sbjct:    57 ASEYNEFCKAVEENLSIDQIKEVLEINGQDCSAPEETLLAQCQDLLFYGALAKCPLCGGT 116

Query:   121 LEFDG-KRYSCKGMYSEWSTCTFRTKDPPRKQEPTKLPDSVLNSPISDLAKRYQDPSHRP 179
             L  D  KR+ C G  SEW +C F TKDPPRK+EP K+PDSV+NS ISDL K++QDP  RP
Sbjct:   117 LICDNEKRFVCGGEISEWCSCVFSTKDPPRKEEPVKIPDSVMNSAISDLIKKHQDPKSRP 176

Query:   180 RRDVGAAVKPFTGMTISLMGRLSRTHQYWRTTIEKHGGKVAASPIGLTCLVASPAERERG 239
             +R++G+A KPF GM ISLMGRL+RTHQYW+  IE++GGKV+ +  G+TCLV SPAERERG
Sbjct:   177 KRELGSADKPFVGMMISLMGRLTRTHQYWKKKIERNGGKVSNTVQGVTCLVVSPAERERG 236

Query:   240 GSSKLVEAMERGTRVVSEAWLIDSIEKQEAQPLEAYDLVTDLAPDSKGIPWDKMDPXXXX 299
             G+SK+VEAME+G  VVSEAWLIDS+EK EAQPLEAYD+V+DL+ + KGIPWDK DP    
Sbjct:   237 GTSKMVEAMEQGLPVVSEAWLIDSVEKHEAQPLEAYDVVSDLSVEGKGIPWDKQDPSEEA 296

Query:   300 XXXXXXXLKLYGKRGVYKDTKLQEQGGKILEKDGILYNCAFSLCDQGRGMNLYCIVQLIT 359
                    LK+YGKRGVY DTKLQE+GGKI EKDG+LYNCAFS+CD G+G N YCI+QL+T
Sbjct:   297 IESFSAELKMYGKRGVYMDTKLQERGGKIFEKDGLLYNCAFSICDLGKGRNEYCIMQLVT 356

Query:   360 VPDSNLHLYYKKGKVGDDPNAEERLEEWTGVDNAIKEFVRLFEEVTGNEFEPWEREKKFQ 419
             VPDSNL++Y+K+GKVGDDPNAEERLEEW   + AIKEF RLFEE+ GNEFEPWEREKK Q
Sbjct:   357 VPDSNLNMYFKRGKVGDDPNAEERLEEWEDEEAAIKEFARLFEEIAGNEFEPWEREKKIQ 416

Query:   420 KKPLKFYPIDMDDGVEVRHGGLGMRQLGVAAAHSKLDPVVANFMKVLCSQEVYRYALMEM 479
             KKP KF+PIDMDDG+EVR G LG+RQLG+A+AH KLD  VANF+KVLC QE+Y YALME+
Sbjct:   417 KKPHKFFPIDMDDGIEVRSGALGLRQLGIASAHCKLDSFVANFIKVLCGQEIYNYALMEL 476

Query:   480 GLDAPDLPIGMLSNVHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLMHSLR 539
             GLD PDLP+GML+++HL RCEEVL +F+E VK+TKETGQKAEA+W DFS+RWF+LMHS R
Sbjct:   477 GLDPPDLPMGMLTDIHLKRCEEVLLEFVEKVKTTKETGQKAEAMWADFSSRWFSLMHSTR 536

Query:   540 PFIFRDNQEIADHAASSFEAVRDITVASHLIGDMSGSTLDDPLSDCYEKLACSISALEKD 599
             P    D  E+ADHAAS+FE VRDI  AS LIGDM G TLDDPLSD Y+KL C IS ++K+
Sbjct:   537 PMRLHDVNELADHAASAFETVRDINTASRLIGDMRGDTLDDPLSDRYKKLGCKISVVDKE 596

Query:   600 SDDYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNAQPSLDEIKKLPNKVLLWCGTR 659
             S+DYKM+V YLE TYEPVK+ D+EYGVSV N+F +ES+A PSLD+IKKLPNKVLLWCG+R
Sbjct:   597 SEDYKMVVKYLETTYEPVKVSDVEYGVSVQNVFAVESDAIPSLDDIKKLPNKVLLWCGSR 656

Query:   660 SSNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLVLAVAS 719
             SSNLLRH+ KGFLPA CSLPVPGYMFGRAIVCSDAAAEAARYGFTA DRPEGFLVLAVAS
Sbjct:   657 SSNLLRHIYKGFLPAVCSLPVPGYMFGRAIVCSDAAAEAARYGFTAVDRPEGFLVLAVAS 716

Query:   720 LGDQVTELKKPPEDTKSLEDXXXXXXXXXXXXTDESEHFFWNDDIKVPGGRLIPSEHKNS 779
             LG++VTE   PPEDTK+LED            T+ESEHF W DDIKVP GRL+PSEHK+S
Sbjct:   717 LGEEVTEFTSPPEDTKTLEDKKIGVKGLGRKKTEESEHFMWRDDIKVPCGRLVPSEHKDS 776

Query:   780 PLEYNEYAVYDPKQTSIRFLVGVKFEERGVEMEPAE 815
             PLEYNEYAVYDPKQTSIRFLV VK+EE+G E+   E
Sbjct:   777 PLEYNEYAVYDPKQTSIRFLVEVKYEEKGTEIVDVE 812




GO:0003950 "NAD+ ADP-ribosyltransferase activity" evidence=IEA;ISS
GO:0005622 "intracellular" evidence=IEA
GO:0005634 "nucleus" evidence=ISM;IEA;ISS
GO:0006471 "protein ADP-ribosylation" evidence=IEA;ISS
TAIR|locus:2042511 PARP1 "POLY(ADP-RIBOSE) POLYMERASE 1" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
UNIPROTKB|P09874 PARP1 "Poly [ADP-ribose] polymerase 1" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|P18493 PARP1 "Poly [ADP-ribose] polymerase 1" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
UNIPROTKB|F1MU08 PARP1 "Poly [ADP-ribose] polymerase 1" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
UNIPROTKB|J9NXE3 PARP1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
UNIPROTKB|F1Q2M3 PARP1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-030131-3955 parp1 "poly (ADP-ribose) polymerase family, member 1" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
RGD|2053 Parp1 "poly (ADP-ribose) polymerase 1" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
UNIPROTKB|I3LDH3 PARP1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

ID ?Name ?Annotated EC number ?Identity ?Query coverage ?Hit coverage ?RBH(Q2H) ?RBH(H2Q) ?
Q9SWB4PARP3_SOYBN2, ., 4, ., 2, ., 3, 00.75460.98650.9865yesno
Q9FK91PARP3_ARATH2, ., 4, ., 2, ., 3, 00.71300.99010.9914yesno
Q0E0Q3PARP3_ORYSJ2, ., 4, ., 2, ., 3, 00.59250.99500.9759yesno
Q1SGF1PARP3_MEDTR2, ., 4, ., 2, ., 3, 00.73190.97790.9974N/Ano

EC Number Prediction by Ezypred Server ?

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

Prediction LevelEC numberConfidence of Prediction
3rd Layer2.4.20.983
3rd Layer2.4.2.300.979

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Fail to connect to STRING server


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query815
PLN03122815 PLN03122, PLN03122, Poly [ADP-ribose] polymerase; 0.0
PLN03123981 PLN03123, PLN03123, poly [ADP-ribose] polymerase; 1e-135
cd01437347 cd01437, parp_like, Poly(ADP-ribose) polymerase (p 1e-114
pfam00644206 pfam00644, PARP, Poly(ADP-ribose) polymerase catal 1e-58
PLN03124643 PLN03124, PLN03124, poly [ADP-ribose] polymerase; 4e-52
cd08001104 cd08001, WGR_PARP1_like, WGR domain of poly(ADP-ri 5e-34
smart0077384 smart00773, WGR, Proposed nucleic acid binding dom 6e-20
pfam0806355 pfam08063, PADR1, PADR1 (NUC008) domain 4e-17
pfam0540683 pfam05406, WGR, WGR domain 6e-13
cd07997102 cd07997, WGR_PARP, WGR domain of poly(ADP-ribose) 6e-09
pfam0053377 pfam00533, BRCT, BRCA1 C Terminus (BRCT) domain 8e-09
pfam02877130 pfam02877, PARP_reg, Poly(ADP-ribose) polymerase, 3e-08
smart0029278 smart00292, BRCT, breast cancer carboxy-terminal d 5e-08
cd0002772 cd00027, BRCT, Breast Cancer Suppressor Protein (B 7e-06
cd01341137 cd01341, ADP_ribosyl, ADP_ribosylating enzymes cat 4e-05
cd08002100 cd08002, WGR_PARP3_like, WGR domain of poly(ADP-ri 4e-05
>gnl|CDD|178669 PLN03122, PLN03122, Poly [ADP-ribose] polymerase; Provisional Back     alignment and domain information
 Score = 1444 bits (3741), Expect = 0.0
 Identities = 630/815 (77%), Positives = 705/815 (86%), Gaps = 1/815 (0%)

Query: 2   KVHETRSHAHASSDEE-KVMTRKQKAENKTQEATETPPKKTKQENNGNGGHANGKRSGDV 60
           KVHETRS AHA + EE K  TRKQKAENK  E  ++P K  K++   + G+ NGK + D 
Sbjct: 1   KVHETRSQAHAPAAEEGKGGTRKQKAENKEHEGEQSPKKAKKEKKQDDSGNGNGKSAEDA 60

Query: 61  TAEFEEFCKSIEGQLSAEQMREILELNGQDSSGSDVAVVTKCLDMLFYGPLDKCPVCNGN 120
             EFEEFCK+IE  LS EQMREILE NGQDSSGSD AV+ +C D LFYGPL+KCP+C G 
Sbjct: 61  VKEFEEFCKAIEEHLSIEQMREILEENGQDSSGSDDAVLPRCQDQLFYGPLEKCPLCGGA 120

Query: 121 LEFDGKRYSCKGMYSEWSTCTFRTKDPPRKQEPTKLPDSVLNSPISDLAKRYQDPSHRPR 180
           LE DG RY+C G  SEWS+CTF TK+PPRK+EP K+PDSV NS I+ L K++QDPS RP+
Sbjct: 121 LECDGHRYTCTGFISEWSSCTFSTKNPPRKEEPLKIPDSVKNSFITKLLKKHQDPSKRPK 180

Query: 181 RDVGAAVKPFTGMTISLMGRLSRTHQYWRTTIEKHGGKVAASPIGLTCLVASPAERERGG 240
           R++GA  KPF+GM ISL GRLSRTHQYW+  IEKHGGKVA S  G+TCLV SPAERERGG
Sbjct: 181 RELGAPGKPFSGMMISLSGRLSRTHQYWKKDIEKHGGKVANSVEGVTCLVVSPAERERGG 240

Query: 241 SSKLVEAMERGTRVVSEAWLIDSIEKQEAQPLEAYDLVTDLAPDSKGIPWDKMDPSEEAI 300
           SSK+ EAMERG  VV EAWLIDSIEKQEAQPLEAYD+V+DL+ + +GIPWDK DPSEEAI
Sbjct: 241 SSKIAEAMERGIPVVREAWLIDSIEKQEAQPLEAYDVVSDLSVEGRGIPWDKQDPSEEAI 300

Query: 301 ESIAAELKLYGKRGVYKDTKLQEQGGKILEKDGILYNCAFSLCDQGRGMNLYCIVQLITV 360
           ES++AELKLYGKRGVYKD+KLQE+GGKI EKDGILYNCAFS+CD GRG+N YCI+QLITV
Sbjct: 301 ESLSAELKLYGKRGVYKDSKLQEEGGKIFEKDGILYNCAFSICDLGRGLNEYCIMQLITV 360

Query: 361 PDSNLHLYYKKGKVGDDPNAEERLEEWTGVDNAIKEFVRLFEEVTGNEFEPWEREKKFQK 420
           PDSNLHLYYKKG+VGDDPNAEERLEEW  VD AIKEFVRLFEE+TGNEFEPWEREKKF+K
Sbjct: 361 PDSNLHLYYKKGRVGDDPNAEERLEEWEDVDAAIKEFVRLFEEITGNEFEPWEREKKFEK 420

Query: 421 KPLKFYPIDMDDGVEVRHGGLGMRQLGVAAAHSKLDPVVANFMKVLCSQEVYRYALMEMG 480
           K LKFYPIDMDDGV+VR GGLG+RQLGVAAAH KLDP VANFMKVLCSQE+YRYA+MEMG
Sbjct: 421 KRLKFYPIDMDDGVDVRAGGLGLRQLGVAAAHCKLDPKVANFMKVLCSQEIYRYAMMEMG 480

Query: 481 LDAPDLPIGMLSNVHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLMHSLRP 540
           LD+PDLP+GMLS+ HL RCEEVL +F E VKS KETGQKAEA+W DFSN+WF+L+HS RP
Sbjct: 481 LDSPDLPMGMLSDFHLKRCEEVLLEFAEFVKSEKETGQKAEAMWLDFSNKWFSLVHSTRP 540

Query: 541 FIFRDNQEIADHAASSFEAVRDITVASHLIGDMSGSTLDDPLSDCYEKLACSISALEKDS 600
           F+ RD  E+ADHAAS+ E VRDI VAS LIGDM+GSTLDDPLSD Y+KL CSIS ++K+S
Sbjct: 541 FVIRDIDELADHAASALETVRDINVASRLIGDMTGSTLDDPLSDRYKKLGCSISPVDKES 600

Query: 601 DDYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNAQPSLDEIKKLPNKVLLWCGTRS 660
           DDYKMIV YLEKTYEPVK+GD+ Y VSV+NIF +ES+A PSLDEIKKLPNKVLLWCGTRS
Sbjct: 601 DDYKMIVKYLEKTYEPVKVGDVSYSVSVENIFAVESSAGPSLDEIKKLPNKVLLWCGTRS 660

Query: 661 SNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLVLAVASL 720
           SNLLRHL KGFLPA CSLPVPGYMFG+AIVCSDAAAEAARYGFTA DRPEGFLVLAVASL
Sbjct: 661 SNLLRHLAKGFLPAVCSLPVPGYMFGKAIVCSDAAAEAARYGFTAVDRPEGFLVLAVASL 720

Query: 721 GDQVTELKKPPEDTKSLEDKKLGVKGLGRKKTDESEHFFWNDDIKVPGGRLIPSEHKNSP 780
           GD+V EL KPPED KS E+KK+GVKGLGRKKTDESEHF W DDI VP GRLIPSEHK+SP
Sbjct: 721 GDEVLELTKPPEDVKSYEEKKVGVKGLGRKKTDESEHFKWRDDITVPCGRLIPSEHKDSP 780

Query: 781 LEYNEYAVYDPKQTSIRFLVGVKFEERGVEMEPAE 815
           LEYNEYAVYDPKQ SIRFLVGVK+EE+G EM  AE
Sbjct: 781 LEYNEYAVYDPKQVSIRFLVGVKYEEKGAEMVTAE 815


Length = 815

>gnl|CDD|215590 PLN03123, PLN03123, poly [ADP-ribose] polymerase; Provisional Back     alignment and domain information
>gnl|CDD|238717 cd01437, parp_like, Poly(ADP-ribose) polymerase (parp) catalytic domain catalyses the covalent attachment of ADP-ribose units from NAD+ to itself and to a limited number of other DNA binding proteins, which decreases their affinity for DNA Back     alignment and domain information
>gnl|CDD|216040 pfam00644, PARP, Poly(ADP-ribose) polymerase catalytic domain Back     alignment and domain information
>gnl|CDD|215591 PLN03124, PLN03124, poly [ADP-ribose] polymerase; Provisional Back     alignment and domain information
>gnl|CDD|153428 cd08001, WGR_PARP1_like, WGR domain of poly(ADP-ribose) polymerase 1 and similar proteins Back     alignment and domain information
>gnl|CDD|214814 smart00773, WGR, Proposed nucleic acid binding domain Back     alignment and domain information
>gnl|CDD|191934 pfam08063, PADR1, PADR1 (NUC008) domain Back     alignment and domain information
>gnl|CDD|218579 pfam05406, WGR, WGR domain Back     alignment and domain information
>gnl|CDD|153426 cd07997, WGR_PARP, WGR domain of poly(ADP-ribose) polymerases Back     alignment and domain information
>gnl|CDD|215978 pfam00533, BRCT, BRCA1 C Terminus (BRCT) domain Back     alignment and domain information
>gnl|CDD|190460 pfam02877, PARP_reg, Poly(ADP-ribose) polymerase, regulatory domain Back     alignment and domain information
>gnl|CDD|214602 smart00292, BRCT, breast cancer carboxy-terminal domain Back     alignment and domain information
>gnl|CDD|237994 cd00027, BRCT, Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain Back     alignment and domain information
>gnl|CDD|238651 cd01341, ADP_ribosyl, ADP_ribosylating enzymes catalyze the transfer of ADP_ribose from NAD+ to substrates Back     alignment and domain information
>gnl|CDD|153429 cd08002, WGR_PARP3_like, WGR domain of poly(ADP-ribose) polymerase 3 and similar proteins Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 815
PLN03122815 Poly [ADP-ribose] polymerase; Provisional 100.0
PLN03123981 poly [ADP-ribose] polymerase; Provisional 100.0
PLN03124643 poly [ADP-ribose] polymerase; Provisional 100.0
cd01437347 parp_like Poly(ADP-ribose) polymerase (parp) catal 100.0
KOG1037531 consensus NAD+ ADP-ribosyltransferase Parp, requir 100.0
PF00644206 PARP: Poly(ADP-ribose) polymerase catalytic domain 100.0
cd01438223 tankyrase_like Tankyrases interact with the telome 100.0
PF02877133 PARP_reg: Poly(ADP-ribose) polymerase, regulatory 99.97
cd08003103 WGR_PARP2_like WGR domain of poly(ADP-ribose) poly 99.97
cd08001104 WGR_PARP1_like WGR domain of poly(ADP-ribose) poly 99.95
cd08002100 WGR_PARP3_like WGR domain of poly(ADP-ribose) poly 99.95
cd07997102 WGR_PARP WGR domain of poly(ADP-ribose) polymerase 99.92
cd01341137 ADP_ribosyl ADP_ribosylating enzymes catalyze the 99.92
cd01439121 TCCD_inducible_PARP_like Poly(ADP-ribose) polymera 99.9
PF0806355 PADR1: PADR1 (NUC008) domain; InterPro: IPR012982 99.87
smart0077384 WGR Proposed nucleic acid binding domain. This dom 99.75
PF0540681 WGR: WGR domain; InterPro: IPR008893 This domain i 99.71
cd0799473 WGR WGR domain. The WGR domain is found in a varie 99.63
cd0799674 WGR_MMR_like WGR domain of molybdate metabolism re 99.34
PF0053378 BRCT: BRCA1 C Terminus (BRCT) domain; InterPro: IP 99.11
PF1273863 PTCB-BRCT: twin BRCT domain; PDB: 3PA6_A 3KTF_C 2W 98.99
COG0272667 Lig NAD-dependent DNA ligase (contains BRCT domain 98.97
PRK06063313 DNA polymerase III subunit epsilon; Provisional 98.93
PRK14350669 ligA NAD-dependent DNA ligase LigA; Provisional 98.93
cd0002772 BRCT Breast Cancer Suppressor Protein (BRCA1), car 98.93
smart0029280 BRCT breast cancer carboxy-terminal domain. 98.85
PRK06195309 DNA polymerase III subunit epsilon; Validated 98.8
PRK14351689 ligA NAD-dependent DNA ligase LigA; Provisional 98.74
PRK07956665 ligA NAD-dependent DNA ligase LigA; Validated 98.67
TIGR00575652 dnlj DNA ligase, NAD-dependent. The member of this 98.6
COG5275276 BRCT domain type II [General function prediction o 98.5
COG383185 Uncharacterized conserved protein [Function unknow 98.26
KOG3226508 consensus DNA repair protein [Replication, recombi 97.92
cd0799877 WGR_DNA_ligase WGR domain of bacterial DNA ligases 97.88
KOG1929811 consensus Nucleotide excision repair factor NEF2, 97.48
PRK05601377 DNA polymerase III subunit epsilon; Validated 96.54
KOG1037531 consensus NAD+ ADP-ribosyltransferase Parp, requir 96.54
KOG0966881 consensus ATP-dependent DNA ligase IV [Replication 96.42
KOG1929811 consensus Nucleotide excision repair factor NEF2, 95.43
KOG2043896 consensus Signaling protein SWIFT and related BRCT 94.84
KOG35481176 consensus DNA damage checkpoint protein RHP9/CRB2/ 94.71
KOG0323635 consensus TFIIF-interacting CTD phosphatases, incl 91.09
COG5163591 NOP7 Protein required for biogenesis of the 60S ri 90.4
KOG2481570 consensus Protein required for normal rRNA process 88.47
KOG3524 850 consensus Predicted guanine nucleotide exchange fa 85.58
>PLN03122 Poly [ADP-ribose] polymerase; Provisional Back     alignment and domain information
Probab=100.00  E-value=9.7e-214  Score=1860.41  Aligned_cols=813  Identities=78%  Similarity=1.257  Sum_probs=751.9

Q ss_pred             cccccccccCCC-chhHhhhhHhhHhhhcccccccCCccccccccC-CCCCCccccchHHHHHHHHHHHHHHHhcCCHHH
Q 037230            2 KVHETRSHAHAS-SDEEKVMTRKQKAENKTQEATETPPKKTKQENN-GNGGHANGKRSGDVTAEFEEFCKSIEGQLSAEQ   79 (815)
Q Consensus         2 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~k~q~~~lw~~~d~l~~~~~~~~   79 (815)
                      ||||||||+||+ ++|+|+|+||||||+|+||+||+ |+|+|+++. +.+++.++++...|+++||+|||+|+++||.++
T Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~q~~~~~~~~d~l~~~~s~~~   79 (815)
T PLN03122          1 KVHETRSQAHAPAAEEGKGGTRKQKAENKEHEGEQS-PKKAKKEKKQDDSGNGNGKSAEDAVKEFEEFCKAIEEHLSIEQ   79 (815)
T ss_pred             CcccccccccccchhhhcccchhhhccccccccccC-chhhhhhcccccCCcccccCHHHHHHHHHHHHHHHHhhCCHHH
Confidence            799999999999 99999999999999999999999 888766651 236777778899999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCChHHHHHHhhhhhhcCCCCCCCCCCCeeEEeCceeEeecCCcCccccccccCCCCCCCCCccCCcc
Q 037230           80 MREILELNGQDSSGSDVAVVTKCLDMLFYGPLDKCPVCNGNLEFDGKRYSCKGMYSEWSTCTFRTKDPPRKQEPTKLPDS  159 (815)
Q Consensus        80 l~~lL~~N~q~~~~~~~~ll~~~aD~~~fG~l~~Cp~C~g~l~~~~~~Y~C~G~~sewtkC~~~~~~p~R~~~~~kiP~~  159 (815)
                      |++||++|+|.++++++.|++||||+|+||+|++||.|+|+|+|++++|+|+|||||||||+|+|++|+|++++|+||++
T Consensus        80 l~~~L~~N~q~~~~~~~~~~~~~aD~m~fG~l~~Cp~C~g~l~~~g~~Y~C~G~iSeWtKC~y~T~~P~R~~~~~kiP~e  159 (815)
T PLN03122         80 MREILEENGQDSSGSDDAVLPRCQDQLFYGPLEKCPLCGGALECDGHRYTCTGFISEWSSCTFSTKNPPRKEEPLKIPDS  159 (815)
T ss_pred             HHHHHHHcCCCCCCcHHHHHHHHhHHHhhcCCCCCCCCCCeEEEcCCeeEeccccCCCcccccccCCCCcccCcccCcHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999997779999999


Q ss_pred             cCCcccchhhcccCCCCCCCccccCCCCCCCCCcEEEEeeccccchHHHHHHHHHcCCEEEeeccceeEEEeChHHHhcC
Q 037230          160 VLNSPISDLAKRYQDPSHRPRRDVGAAVKPFTGMTISLMGRLSRTHQYWRTTIEKHGGKVAASPIGLTCLVASPAERERG  239 (815)
Q Consensus       160 ~~~~fl~~~~~~~~~~~~~p~r~~~p~~~~L~g~~~~isG~l~~~r~elk~~Ie~~GG~v~~~vs~~thlI~t~~e~~k~  239 (815)
                      +++.||++|+++++++..+|.|...|+.+||.|++|+|+|+|+.+|++++++|+++||+|+++|+++||+|++.++++++
T Consensus       160 ~k~~fl~~~k~~~~~~~~~p~~~~~~~~kpL~G~~fviTGtl~~sr~elK~~Ie~~GGkvsssVs~~T~lIvt~~ev~k~  239 (815)
T PLN03122        160 VKNSFITKLLKKHQDPSKRPKRELGAPGKPFSGMMISLSGRLSRTHQYWKKDIEKHGGKVANSVEGVTCLVVSPAERERG  239 (815)
T ss_pred             HHHHHHHHhcccccccccCccccccccCCCcCCcEEEEeCCCCCCHHHHHHHHHHcCCEEccccccceEEEEcCcccccc
Confidence            99889999999888888888887778888999999999999998999999999999999999999777889999888776


Q ss_pred             CchhHHHHHHcCCcEechhHHHHHhhhcCCCCCcccccccCCCCCCCCCCCCCCCCChHHHHHHHHHHHHhcCccCCCCC
Q 037230          240 GSSKLVEAMERGTRVVSEAWLIDSIEKQEAQPLEAYDLVTDLAPDSKGIPWDKMDPSEEAIESIAAELKLYGKRGVYKDT  319 (815)
Q Consensus       240 ~s~K~~~A~~~gI~IVsed~L~d~~~~~~~l~~~~Y~i~s~~~~~~~~~~~~k~d~~~~~~~s~~~k~k~kg~~~Vd~~s  319 (815)
                      +++|+++|+++|||||+|+||.+|+..++.+++.+|.+.++...+++..||.+.+++..+..+...+++++|+++||++|
T Consensus       240 gsSKlkkAk~lgIpIVsEd~L~d~i~~~k~~~~~~y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~k~~~~V~~~~  319 (815)
T PLN03122        240 GSSKIAEAMERGIPVVREAWLIDSIEKQEAQPLEAYDVVSDLSVEGRGIPWDKQDPSEEAIESLSAELKLYGKRGVYKDS  319 (815)
T ss_pred             CccHHHHHHHcCCcCccHHHHHHHHhcCCcccchhhhhccccccccccCcccccCCcccccccccchhccccCcCCCccc
Confidence            45899999999999999999999999999999999999866656667778887665554434456678889999999999


Q ss_pred             ccccCCceEEEeCCeEEEEEEeeecCCCCcccEEEEEEEEcCCCCeEEEEEeeccCCCCcccccccCCCCHHHHHHHHHH
Q 037230          320 KLQEQGGKILEKDGILYNCAFSLCDQGRGMNLYCIVQLITVPDSNLHLYYKKGKVGDDPNAEERLEEWTGVDNAIKEFVR  399 (815)
Q Consensus       320 ~l~~~~~hVy~d~~~~Y~~~L~~tDi~~~~NkfY~lQlle~~~~~y~vf~~wGRVG~~~~g~~k~~~~~s~e~Ai~~F~k  399 (815)
                      ++...++|||+++|.+|+|+|++||+++|+|+||+||||+++.+.||||+||||||+.|.+++++++|.++++|+.+|++
T Consensus       320 ~l~~~~~~V~~~~~~iYd~~Lnqtd~~~n~NkfY~iQlL~~~~~~y~~~~rWGRVG~~gq~~~~~~~~~~~~~Ai~~F~k  399 (815)
T PLN03122        320 KLQEEGGKIFEKDGILYNCAFSICDLGRGLNEYCIMQLITVPDSNLHLYYKKGRVGDDPNAEERLEEWEDVDAAIKEFVR  399 (815)
T ss_pred             ccccCccEEEecCCeEeeeeeeeeeccCCCcceEEEEEEEcCCCcEEEEeeecccCCcCCCccccCCCCCHHHHHHHHHH
Confidence            98845999999999999999999999999999999999998777899999999999987667788999999999999999


Q ss_pred             HHHHHhcCCCccccccccCccCCCCccccccCCccccccCCCCcccccccCCCCCCCHHHHHHHHHHhCHHHHHHHHHHc
Q 037230          400 LFEEVTGNEFEPWEREKKFQKKPLKFYPIDMDDGVEVRHGGLGMRQLGVAAAHSKLDPVVANFMKVLCSQEVYRYALMEM  479 (815)
Q Consensus       400 ~F~eKTgn~w~~w~~r~~f~k~pgKy~~v~~d~~~~~~~~~~~~~~~~~~~~~s~L~~~Vq~Li~~I~d~~~~~~~~~e~  479 (815)
                      +|++||||+|++|++|.+|+++||||+|+++||+.+++.+.....+.+....+|+|+++||+||++|||+++|+++|++|
T Consensus       400 kF~eKTgn~~~~w~~r~~F~k~pgky~~id~d~~~~~~~~~~~~~~~~~~~~~skL~~~Vq~L~~lIfd~~~m~~~m~e~  479 (815)
T PLN03122        400 LFEEITGNEFEPWEREKKFEKKRLKFYPIDMDDGVDVRAGGLGLRQLGVAAAHCKLDPKVANFMKVLCSQEIYRYAMMEM  479 (815)
T ss_pred             HHHHHhCCCccccccccCccccCCCCceeeccccccccccccchhhcccccCCCCCCHHHHHHHHHHcCHHHHHHHHHHc
Confidence            99999999999999999999999999999999998765433233333345678999999999999999999999999999


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcccccchhhHHHHHHhhhhccccccCCCCccCCCHHHHHHHHHHHHHH
Q 037230          480 GLDAPDLPIGMLSNVHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLMHSLRPFIFRDNQEIADHAASSFEA  559 (815)
Q Consensus       480 ~~d~~k~PLGkLS~~qI~~a~~vL~ei~~~l~~~~~~~~~~~~~l~~lsn~fYtlIPh~~p~~i~~~~~l~~k~~~lle~  559 (815)
                      +||+.+||||+||+.||.+||+||.+|+++|.+........+..+.+|||+|||+|||.+||+|+|.+.|++|+++|||+
T Consensus       480 ~~D~~kmPLGKLSk~qI~~g~~vL~ei~~~l~~~~~~~~~~~~~~~dlSnrfYTlIPh~~ppvi~~~~~lk~k~~~mLe~  559 (815)
T PLN03122        480 GLDSPDLPMGMLSDFHLKRCEEVLLEFAEFVKSEKETGQKAEAMWLDFSNKWFSLVHSTRPFVIRDIDELADHAASALET  559 (815)
T ss_pred             CCCcccCCCCcCCHHHHHHHHHHHHHHHHHHhccccccchhHHHHHHHhccceeccCCCCCCCCCCHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999998765433334467999999999999999999999999999994499999


Q ss_pred             HHHHHHHHHhhhcccCCCCCCcchhhhhhcCceeEEcCCCCHHHHHHHHHHHhccCCCccCCcccccccceeeeEecCCc
Q 037230          560 VRDITVASHLIGDMSGSTLDDPLSDCYEKLACSISALEKDSDDYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNAQ  639 (815)
Q Consensus       560 L~die~A~~ll~~~~~~~~~~pld~~Y~~L~~~i~~L~~~s~ey~~I~~y~~~t~~~~h~~~~~~~~~I~~If~v~r~~~  639 (815)
                      |.||++|++|+++....+..||||.+|++|+|+|+||+++|+||++|++|+.+||++||+++..|+++|.+||+|+|.+.
T Consensus       560 L~DIeiA~~ll~~~~~~~~~~pLd~~Y~~L~~~i~pLd~~S~eyk~I~~Yl~nT~~~th~~~~~y~l~v~~IF~veR~ge  639 (815)
T PLN03122        560 VRDINVASRLIGDMTGSTLDDPLSDRYKKLGCSISPVDKESDDYKMIVKYLEKTYEPVKVGDVSYSVSVENIFAVESSAG  639 (815)
T ss_pred             HHHHHHHHHHHhhccccccCCchHHHHHhcCceEEEcCCCCHHHHHHHHHHHhcCCCccccCcccceeEeEEEEeccCcc
Confidence            99999999999764445678999999999999999999999999999999999999999766789999999999999997


Q ss_pred             cchhhhhcCCCceeeeccCCccchhhhcccCCCCCCCCCCCCCceeeeeeeechhhhhhhcccccCCCCCceEEEEEEEe
Q 037230          640 PSLDEIKKLPNKVLLWCGTRSSNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLVLAVAS  719 (815)
Q Consensus       640 ~~f~~~~~~~N~~lLwHGSr~~N~~gIL~~Gl~iap~~a~~tG~mFGkGIYFAd~~skS~~Yc~~~~~~~~~~mlLceVa  719 (815)
                      +||.+|++++||+|||||||.+||+|||+||||||||+||+||||||||||||||+||||+||+++.++++|+|||||||
T Consensus       640 ~rf~~~~~l~NR~LLWHGSR~tN~~gILsqGLRIAPPEAPvtGYMFGKGIYFAD~~SKSAnYC~t~~~~~~GlLlLcEVA  719 (815)
T PLN03122        640 PSLDEIKKLPNKVLLWCGTRSSNLLRHLAKGFLPAVCSLPVPGYMFGKAIVCSDAAAEAARYGFTAVDRPEGFLVLAVAS  719 (815)
T ss_pred             ccchhhcCCCCceEEeccchhhhHHHHhhCCCccCCcccCCCCCccCCeeEecchhhhhhhhhccccCCCcceEEEEHhh
Confidence            79999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCcceeccCCCCcCccCCCCCcceeeeccccCCCCCceeecCCeEecCCCcccCCCCCCCCCCceEEEecCCCcceeeE
Q 037230          720 LGDQVTELKKPPEDTKSLEDKKLGVKGLGRKKTDESEHFFWNDDIKVPGGRLIPSEHKNSPLEYNEYAVYDPKQTSIRFL  799 (815)
Q Consensus       720 LG~~~~e~~~~~~~~~~~p~G~~Sv~g~G~~~Pdp~~~~~~~dgv~vP~G~~~~~~~~~~~l~ynEyIVYd~~Qv~~rYL  799 (815)
                      ||++++|+..++.++.++|+|+|||+|+|++.|||+++++|+|||.||+|+++++...+++|.||||||||++|||||||
T Consensus       720 LG~~~~el~~~~~~~~~~~~g~~Stkg~G~~~Pdp~~~~~~~dgV~VP~Gk~~~~~~~~~~L~yNEYIVYDvaQvrirYL  799 (815)
T PLN03122        720 LGDEVLELTKPPEDVKSYEEKKVGVKGLGRKKTDESEHFKWRDDITVPCGRLIPSEHKDSPLEYNEYAVYDPKQVSIRFL  799 (815)
T ss_pred             cCchHHHhhcCchhhhccCCCCceeeecCCCcCCCccceecCCCeEEeCCCCccCCCCCcccccCceEEEchhHEEEEEE
Confidence            99944899999668899999999999999999999999999999999999999988878899999999999999999999


Q ss_pred             EEEEeccccccccCCC
Q 037230          800 VGVKFEERGVEMEPAE  815 (815)
Q Consensus       800 v~~~~~~~~~~~~~~~  815 (815)
                      |+|+|+|+++|||++|
T Consensus       800 ~~vkf~~~~~~~~~~~  815 (815)
T PLN03122        800 VGVKYEEKGAEMVTAE  815 (815)
T ss_pred             EEEEeecceeEeecCC
Confidence            9999999999999987



>PLN03123 poly [ADP-ribose] polymerase; Provisional Back     alignment and domain information
>PLN03124 poly [ADP-ribose] polymerase; Provisional Back     alignment and domain information
>cd01437 parp_like Poly(ADP-ribose) polymerase (parp) catalytic domain catalyses the covalent attachment of ADP-ribose units from NAD+ to itself and to a limited number of other DNA binding proteins, which decreases their affinity for DNA Back     alignment and domain information
>KOG1037 consensus NAD+ ADP-ribosyltransferase Parp, required for poly-ADP ribosylation of nuclear proteins [Transcription; Replication, recombination and repair; Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PF00644 PARP: Poly(ADP-ribose) polymerase catalytic domain; InterPro: IPR012317 Poly(ADP-ribose) polymerases (PARP) are a family of enzymes present in eukaryotes, which catalyze the poly(ADP-ribosyl)ation of a limited number of proteins involved in chromatin architecture, DNA repair, or in DNA metabolism, including PARP itself Back     alignment and domain information
>cd01438 tankyrase_like Tankyrases interact with the telomere reverse transcriptase complex (TERT) Back     alignment and domain information
>PF02877 PARP_reg: Poly(ADP-ribose) polymerase, regulatory domain; InterPro: IPR004102 Poly(ADP-ribose) polymerase catalyses the covalent attachment of ADP-ribose units from NAD+ to itself and to a limited number of other DNA binding proteins, which decreases their affinity for DNA Back     alignment and domain information
>cd08003 WGR_PARP2_like WGR domain of poly(ADP-ribose) polymerases Back     alignment and domain information
>cd08001 WGR_PARP1_like WGR domain of poly(ADP-ribose) polymerase 1 and similar proteins Back     alignment and domain information
>cd08002 WGR_PARP3_like WGR domain of poly(ADP-ribose) polymerase 3 and similar proteins Back     alignment and domain information
>cd07997 WGR_PARP WGR domain of poly(ADP-ribose) polymerases Back     alignment and domain information
>cd01341 ADP_ribosyl ADP_ribosylating enzymes catalyze the transfer of ADP_ribose from NAD+ to substrates Back     alignment and domain information
>cd01439 TCCD_inducible_PARP_like Poly(ADP-ribose) polymerases catalyse the covalent attachment of ADP-ribose units from NAD+ to itself and to a limited number of other DNA binding proteins, which decreases their affinity for DNA Back     alignment and domain information
>PF08063 PADR1: PADR1 (NUC008) domain; InterPro: IPR012982 This domain is found in poly(ADP-ribose)-synthetases [] Back     alignment and domain information
>smart00773 WGR Proposed nucleic acid binding domain Back     alignment and domain information
>PF05406 WGR: WGR domain; InterPro: IPR008893 This domain is named after the most conserved central motif of the domain Back     alignment and domain information
>cd07994 WGR WGR domain Back     alignment and domain information
>cd07996 WGR_MMR_like WGR domain of molybdate metabolism regulator and related proteins Back     alignment and domain information
>PF00533 BRCT: BRCA1 C Terminus (BRCT) domain; InterPro: IPR001357 The BRCT domain (after the C_terminal domain of a breast cancer susceptibility protein) is found predominantly in proteins involved in cell cycle checkpoint functions responsive to DNA damage [], for example as found in the breast cancer DNA-repair protein BRCA1 Back     alignment and domain information
>PF12738 PTCB-BRCT: twin BRCT domain; PDB: 3PA6_A 3KTF_C 2WT8_C 3EF1_A 3EF0_A Back     alignment and domain information
>COG0272 Lig NAD-dependent DNA ligase (contains BRCT domain type II) [DNA replication, recombination, and repair] Back     alignment and domain information
>PRK06063 DNA polymerase III subunit epsilon; Provisional Back     alignment and domain information
>PRK14350 ligA NAD-dependent DNA ligase LigA; Provisional Back     alignment and domain information
>cd00027 BRCT Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain Back     alignment and domain information
>smart00292 BRCT breast cancer carboxy-terminal domain Back     alignment and domain information
>PRK06195 DNA polymerase III subunit epsilon; Validated Back     alignment and domain information
>PRK14351 ligA NAD-dependent DNA ligase LigA; Provisional Back     alignment and domain information
>PRK07956 ligA NAD-dependent DNA ligase LigA; Validated Back     alignment and domain information
>TIGR00575 dnlj DNA ligase, NAD-dependent Back     alignment and domain information
>COG5275 BRCT domain type II [General function prediction only] Back     alignment and domain information
>COG3831 Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG3226 consensus DNA repair protein [Replication, recombination and repair] Back     alignment and domain information
>cd07998 WGR_DNA_ligase WGR domain of bacterial DNA ligases Back     alignment and domain information
>KOG1929 consensus Nucleotide excision repair factor NEF2, RAD4/CUT5 component [Replication, recombination and repair] Back     alignment and domain information
>PRK05601 DNA polymerase III subunit epsilon; Validated Back     alignment and domain information
>KOG1037 consensus NAD+ ADP-ribosyltransferase Parp, required for poly-ADP ribosylation of nuclear proteins [Transcription; Replication, recombination and repair; Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG0966 consensus ATP-dependent DNA ligase IV [Replication, recombination and repair] Back     alignment and domain information
>KOG1929 consensus Nucleotide excision repair factor NEF2, RAD4/CUT5 component [Replication, recombination and repair] Back     alignment and domain information
>KOG2043 consensus Signaling protein SWIFT and related BRCT domain proteins [Transcription; Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Replication, recombination and repair] Back     alignment and domain information
>KOG3548 consensus DNA damage checkpoint protein RHP9/CRB2/53BP1 [Replication, recombination and repair] Back     alignment and domain information
>KOG0323 consensus TFIIF-interacting CTD phosphatases, including NLI-interacting factor [Transcription] Back     alignment and domain information
>COG5163 NOP7 Protein required for biogenesis of the 60S ribosomal subunit [Translation, ribosomal structure and biogenesis] Back     alignment and domain information
>KOG2481 consensus Protein required for normal rRNA processing [RNA processing and modification] Back     alignment and domain information
>KOG3524 consensus Predicted guanine nucleotide exchange factor (PEBBLE) [Signal transduction mechanisms] Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query815
4dqy_C506 Structure Of Human Parp-1 Bound To A Dna Double Str 2e-47
2rd6_A350 Parp Complexed With A861695 Length = 350 7e-32
1a26_A361 The Catalytic Fragment Of Poly(Adp-Ribose) Polymera 2e-31
1uk0_A350 Crystal Structure Of Catalytic Domain Of Human Poly 2e-31
1efy_A350 Crystal Structure Of The Catalytic Fragment Of Poly 7e-31
1gs0_A351 Crystal Structure Of The Catalytic Fragment Of Muri 5e-30
3kcz_A368 Human Poly(Adp-Ribose) Polymerase 2, Catalytic Frag 1e-25
3c49_A357 Human Poly(Adp-Ribose) Polymerase 3, Catalytic Frag 1e-10
2cr9_A139 Solution Structure Of Wgr Domain Of Poly(Adp-Ribose 5e-09
2riq_A160 Crystal Structure Of The Third Zinc-Binding Domain 7e-07
2jvn_A126 Domain C Of Human Parp-1 Length = 126 1e-06
>pdb|4DQY|C Chain C, Structure Of Human Parp-1 Bound To A Dna Double Strand Break Length = 506 Back     alignment and structure

Iteration: 1

Score = 187 bits (475), Expect = 2e-47, Method: Compositional matrix adjust. Identities = 148/504 (29%), Positives = 244/504 (48%), Gaps = 27/504 (5%) Query: 307 LKLYGKRGVYKDTKLQEQGGKILEKDGILYNCAFSLCDQGRGMNLYCIVQLITVPDSNLH 366 L L G V D+ L E +LEK G +++ L D +G N Y +QL+ N + Sbjct: 9 LTLKGGAAVDPDSGL-EHSAHVLEKGGKVFSATLGLVDIVKGTNSYYKLQLLEDDKENRY 67 Query: 367 LYYKK-GKVGDDPNAEERLEEWTGVDNAIKEFVRLFEEVTGNEFEPWEREKKFQKKPLKF 425 ++ G+VG + +LE+ ++AI+ F++L+EE TGN + K F K P KF Sbjct: 68 WIFRSWGRVGTVIGSN-KLEQMPSKEDAIEHFMKLYEEKTGNAW----HSKNFTKYPKKF 122 Query: 426 YPIDMDDGVEVRHGGLGMRQLGV-AAAHSKLDPVVANFMKVLCSQEVYRYALMEMGLDAP 484 YP+++D G + +++L V SKL V + +K++ E + A++E +D Sbjct: 123 YPLEIDYGQDEE----AVKKLTVNPGTKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQ 178 Query: 485 DLPIGMLSNVHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLM---HSLRPF 541 +P+G LS + +L + +AV Q D SNR++TL+ ++ Sbjct: 179 KMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQ-----ILDLSNRFYTLIPHDFGMKKP 233 Query: 542 IFRDNQEIADHAASSFEAVRDITVASHLIGDMSGSTLDDPLSDCYEKLACSISALEKDSD 601 +N + A + + DI VA L+ S + DP+ YEKL I +++DS+ Sbjct: 234 PLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSE 293 Query: 602 DYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNAQ-PSLDEIKKLPNKVLLWCGTRS 660 + ++I Y++ T+ Y + V +IF IE + K+L N+ LLW G+R+ Sbjct: 294 EAEIIRKYVKNTHATTHNA---YDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRT 350 Query: 661 SNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLVLAVASL 720 +N L +G A PV GYMFG+ I +D +++A Y T+ P G ++L +L Sbjct: 351 TNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVAL 410 Query: 721 GDQVTELKKPPEDTKSLEDXXXXXXXXXXXXTDESEHFFWNDDIKVPGGRLIPSEHKNSP 780 G+ + ELK +K L D S + D + VP G I S ++ Sbjct: 411 GN-MYELKHASHISK-LPKGKHSVKGLGKTTPDPSANISL-DGVDVPLGTGISSGVNDTS 467 Query: 781 LEYNEYAVYDPKQTSIRFLVGVKF 804 L YNEY VYD Q ++++L+ +KF Sbjct: 468 LLYNEYIVYDIAQVNLKYLLKLKF 491
>pdb|2RD6|A Chain A, Parp Complexed With A861695 Length = 350 Back     alignment and structure
>pdb|1A26|A Chain A, The Catalytic Fragment Of Poly(Adp-Ribose) Polymerase Complexed With Carba-Nad Length = 361 Back     alignment and structure
>pdb|1UK0|A Chain A, Crystal Structure Of Catalytic Domain Of Human Poly(Adp- Ribose) Polymerase With A Novel Inhibitor Length = 350 Back     alignment and structure
>pdb|1EFY|A Chain A, Crystal Structure Of The Catalytic Fragment Of Poly (Adp- Ribose) Polymerase Complexed With A Benzimidazole Inhibitor Length = 350 Back     alignment and structure
>pdb|1GS0|A Chain A, Crystal Structure Of The Catalytic Fragment Of Murine Poly (Adp-Ribose) Polymerase-2 Length = 351 Back     alignment and structure
>pdb|3KCZ|A Chain A, Human Poly(Adp-Ribose) Polymerase 2, Catalytic Fragment In Complex With An Inhibitor 3-Aminobenzamide Length = 368 Back     alignment and structure
>pdb|3C49|A Chain A, Human Poly(Adp-Ribose) Polymerase 3, Catalytic Fragment In Complex With An Inhibitor Ku0058948 Length = 357 Back     alignment and structure
>pdb|2CR9|A Chain A, Solution Structure Of Wgr Domain Of Poly(Adp-Ribose) Polymerase-1 Length = 139 Back     alignment and structure
>pdb|2RIQ|A Chain A, Crystal Structure Of The Third Zinc-Binding Domain Of Human Parp-1 Length = 160 Back     alignment and structure
>pdb|2JVN|A Chain A, Domain C Of Human Parp-1 Length = 126 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query815
4dqy_C506 Poly [ADP-ribose] polymerase 1; PARP, poly(ADP-rib 5e-94
1efy_A350 Poly (ADP-ribose) polymerase; benzimidazole, inhib 1e-76
3kjd_A368 Poly [ADP-ribose] polymerase 2; transferase, enzym 1e-73
3c4h_A357 Poly(ADP-ribose) polymerase 3; enzyme-inhibitor co 3e-61
2riq_A160 Poly [ADP-ribose] polymerase 1; Zn-binding domain, 3e-32
2eoc_A124 Poly [ADP-ribose] polymerase 3; anti-parallel beta 2e-21
2cok_A113 Poly [ADP-ribose] polymerase-1; BRCT domain, DNA r 2e-17
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 3e-11
4f0d_A277 PARP-16, poly [ADP-ribose] polymerase 16; transfer 3e-11
3smj_A193 Poly [ADP-ribose] polymerase 14; diphtheria toxin 9e-11
2d8m_A129 DNA-repair protein XRCC1; parallel beta-sheet, DNA 3e-10
2pqf_A198 Poly [ADP-ribose] polymerase 12; enzyme-inhibitor 9e-10
3l3e_A107 DNA topoisomerase 2-binding protein 1; BRCT domain 2e-09
3blj_A221 Poly(ADP-ribose) polymerase 15; PARP, BAL-3, SGC, 2e-09
2ebw_A97 DNA repair protein REV1; A/B/A 3 layers, parallel 2e-09
3sqd_A219 PAX-interacting protein 1; tandem BRCT domains, ce 5e-09
3sqd_A219 PAX-interacting protein 1; tandem BRCT domains, ce 4e-05
3olc_X298 DNA topoisomerase 2-binding protein 1; BRCT domain 3e-08
3hkv_A217 PARP-10, poly [ADP-ribose] polymerase 10; NAD, tra 4e-08
3u9h_A240 Tankyrase-2; protein-ligand complex, diphtheria to 7e-08
3l46_A112 Protein ECT2; alternative splicing, guanine-nucleo 1e-07
2cou_A109 ECT2 protein; BRCT domain, RHO GTPase, structural 1e-07
1l7b_A92 DNA ligase; BRCT, autostructure, structural genomi 4e-07
1wf6_A132 Similar to S.pombe -RAD4+/CUT5+product (A40727); B 5e-07
1t15_A214 Breast cancer type 1 susceptibility protein; prote 2e-06
1t15_A214 Breast cancer type 1 susceptibility protein; prote 5e-05
1l0b_A229 BRCA1; TANDEM-BRCT, three-helix bundle, unknown fu 7e-06
1z56_C264 DNA ligase IV; DNA repair, BRCT, NHEJ, XRCC4, DNA 9e-06
3ii6_X263 DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alter 1e-05
3ii6_X263 DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alter 3e-05
2etx_A209 Mediator of DNA damage checkpoint protein 1; tande 1e-05
2etx_A209 Mediator of DNA damage checkpoint protein 1; tande 2e-04
3u3z_A199 Microcephalin; DNA repair, cell cycle regulation, 2e-05
3l41_A220 BRCT-containing protein 1; BRC1, BRCT domain, tand 3e-05
1dgs_A667 DNA ligase; AMP complex, NAD+-dependent; HET: DNA 5e-05
2ebu_A112 Replication factor C subunit 1; A/B/A 3 layers, pa 9e-05
2k6g_A109 Replication factor C subunit 1; protein, BRCT, DNA 1e-04
1kzy_C259 Tumor suppressor P53-binding protein 1; tandem-BRC 1e-04
3al2_A235 DNA topoisomerase 2-binding protein 1; BRCT domain 1e-04
3al2_A235 DNA topoisomerase 2-binding protein 1; BRCT domain 4e-04
2nte_A210 BARD-1, BRCA1-associated ring domain protein 1; BR 3e-04
>4dqy_C Poly [ADP-ribose] polymerase 1; PARP, poly(ADP-ribose) polymerase, DNA binding protein, ADP- transferase, PARP-like zinc finger, poly(ADP-ribosyl)ation; HET: DNA; 3.25A {Homo sapiens} PDB: 2cr9_A Length = 506 Back     alignment and structure
 Score =  302 bits (775), Expect = 5e-94
 Identities = 151/513 (29%), Positives = 246/513 (47%), Gaps = 27/513 (5%)

Query: 301 ESIAAELKLYGKRGVYKDTKLQEQGGKILEKDGILYNCAFSLCDQGRGMNLYCIVQLITV 360
                +L L G   V  D+ L+     +LEK G +++    L D  +G N Y  +QL+  
Sbjct: 3   SEKRMKLTLKGGAAVDPDSGLEH-SAHVLEKGGKVFSATLGLVDIVKGTNSYYKLQLLED 61

Query: 361 PDSNLH-LYYKKGKVGDDPNAEERLEEWTGVDNAIKEFVRLFEEVTGNEFEPWEREKKFQ 419
              N + ++   G+VG       +LE+    ++AI+ F++L+EE TGN +      K F 
Sbjct: 62  DKENRYWIFRSWGRVGTV-IGSNKLEQMPSKEDAIEHFMKLYEEKTGNAWH----SKNFT 116

Query: 420 KKPLKFYPIDMDDGVEVRHGGLGMRQLGVAAAHSKLDPVVANFMKVLCSQEVYRYALMEM 479
           K P KFYP+++D G +        +        SKL   V + +K++   E  + A++E 
Sbjct: 117 KYPKKFYPLEIDYGQDEEAV---KKLTVNPGTKSKLPKPVQDLIKMIFDVESMKKAMVEY 173

Query: 480 GLDAPDLPIGMLSNVHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLMHS-- 537
            +D   +P+G LS   +     +L +  +AV       Q       D SNR++TL+    
Sbjct: 174 EIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQ-----ILDLSNRFYTLIPHDF 228

Query: 538 --LRPFIFRDNQEIADHAASSFEAVRDITVASHLIGDMSGSTLDDPLSDCYEKLACSISA 595
              +P +  +   +   A    + + DI VA  L+   S  +  DP+   YEKL   I  
Sbjct: 229 GMKKPPLLNNADSVQAKAEM-LDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKV 287

Query: 596 LEKDSDDYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIE-SNAQPSLDEIKKLPNKVLL 654
           +++DS++ ++I  Y++ T+         Y + V +IF IE           K+L N+ LL
Sbjct: 288 VDRDSEEAEIIRKYVKNTHATTH---NAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLL 344

Query: 655 WCGTRSSNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLV 714
           W G+R++N    L +G   A    PV GYMFG+ I  +D  +++A Y  T+   P G ++
Sbjct: 345 WHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLIL 404

Query: 715 LAVASLGDQVTELKKPPEDTKSLEDKKLGVKGLGRKKTDESEHFFWNDDIKVPGGRLIPS 774
           L   +LG+   ELK     +K L   K  VKGLG+   D S +    D + VP G  I S
Sbjct: 405 LGEVALGNM-YELKHASHISK-LPKGKHSVKGLGKTTPDPSANISL-DGVDVPLGTGISS 461

Query: 775 EHKNSPLEYNEYAVYDPKQTSIRFLVGVKFEER 807
              ++ L YNEY VYD  Q ++++L+ +KF  +
Sbjct: 462 GVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFK 494


>1efy_A Poly (ADP-ribose) polymerase; benzimidazole, inhibitor, catalytic fragment, transferase; HET: BZC; 2.20A {Gallus gallus} SCOP: a.41.1.1 d.166.1.2 PDB: 1a26_A* 1pax_A* 2paw_A 2pax_A* 3pax_A* 4pax_A* 2rcw_A* 1uk1_A* 1wok_A* 1uk0_A* 2rd6_A* 3gjw_A* 3gn7_A* 3l3l_A* 3l3m_A* Length = 350 Back     alignment and structure
>3kjd_A Poly [ADP-ribose] polymerase 2; transferase, enzyme-inhibitor complex, catalytic fragment, S genomics, structural genomics consortium, SGC; HET: 78P; 1.95A {Homo sapiens} PDB: 3kcz_A* 1gs0_A Length = 368 Back     alignment and structure
>3c4h_A Poly(ADP-ribose) polymerase 3; enzyme-inhibitor complex, catalytic fragment, structural GEN structural genomics consortium, SGC; HET: DRL; 2.10A {Homo sapiens} PDB: 3c49_A* 2pa9_A* 3ce0_A* 3fhb_A* Length = 357 Back     alignment and structure
>2riq_A Poly [ADP-ribose] polymerase 1; Zn-binding domain, Zn ribbon, Zn finger, ADP-ribosylation, D damage, DNA repair, DNA-binding, glycosyltransferase; 1.70A {Homo sapiens} PDB: 2jvn_A Length = 160 Back     alignment and structure
>2eoc_A Poly [ADP-ribose] polymerase 3; anti-parallel beta-sheet, cell cycle control, DNA damage, transcription, NAD+, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 124 Back     alignment and structure
>2cok_A Poly [ADP-ribose] polymerase-1; BRCT domain, DNA repair, structural genomics, NPPSFA; NMR {Homo sapiens} PDB: 2le0_A Length = 113 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>4f0d_A PARP-16, poly [ADP-ribose] polymerase 16; transferase, ARTD15, structural genomics structural genomics consortium, SGC; HET: 3AB; 2.70A {Homo sapiens} Length = 277 Back     alignment and structure
>3smj_A Poly [ADP-ribose] polymerase 14; diphtheria toxin like fold, transferase, NAD+, ADP-ribosylat transferase-transferase inhibitor complex; HET: FDR; 1.50A {Homo sapiens} PDB: 3goy_A* 3smi_A* 3se2_A* Length = 193 Back     alignment and structure
>2d8m_A DNA-repair protein XRCC1; parallel beta-sheet, DNA ligase III, poly(ADP-ribose) polymerase-1, DNA polymerase beta, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 129 Back     alignment and structure
>2pqf_A Poly [ADP-ribose] polymerase 12; enzyme-inhibitor complex, catalytic fragment, structural GEN structural genomics consortium, SGC, transferase; HET: GAB CIT; 2.20A {Homo sapiens} Length = 198 Back     alignment and structure
>3blj_A Poly(ADP-ribose) polymerase 15; PARP, BAL-3, SGC, structural GE consortium, glycosyltransferase, NAD, nucleus; 2.20A {Homo sapiens} PDB: 3gey_A* Length = 221 Back     alignment and structure
>2ebw_A DNA repair protein REV1; A/B/A 3 layers, parallel beta-sheet, DNA replication, translession synthesis, TLS, DNA polymerase zeta, PCNA; HET: DNA; NMR {Homo sapiens} Length = 97 Back     alignment and structure
>3sqd_A PAX-interacting protein 1; tandem BRCT domains, cell cycle; HET: SEP; 2.15A {Homo sapiens} Length = 219 Back     alignment and structure
>3sqd_A PAX-interacting protein 1; tandem BRCT domains, cell cycle; HET: SEP; 2.15A {Homo sapiens} Length = 219 Back     alignment and structure
>3olc_X DNA topoisomerase 2-binding protein 1; BRCT domain, DNA repair, RAD9, DNA binding protein; HET: DNA; 2.40A {Homo sapiens} PDB: 2xnk_A* 2xnh_A* Length = 298 Back     alignment and structure
>3hkv_A PARP-10, poly [ADP-ribose] polymerase 10; NAD, transferase, structural genomics, structural genomics consortium, SGC, cytoplasm, glycosyltransferase; HET: 3AB; 2.10A {Homo sapiens} Length = 217 Back     alignment and structure
>3u9h_A Tankyrase-2; protein-ligand complex, diphtheria toxin like fold, transfer ribosylation; HET: SO4; 1.75A {Homo sapiens} PDB: 3kr8_A* 3kr7_A* 3p0n_A* 3p0p_A* 3p0q_A* 3mhj_A* 3u9y_A* 3ua9_A* 4avu_A* 4avw_A* 3mhk_A* 2rf5_A 3udd_A* 3uh2_A* 3uh4_A* 4dvi_A* Length = 240 Back     alignment and structure
>3l46_A Protein ECT2; alternative splicing, guanine-nucleotide releasing factor, phosphoprotein, polymorphism, proto-oncogene, structural genomics; 1.48A {Homo sapiens} Length = 112 Back     alignment and structure
>2cou_A ECT2 protein; BRCT domain, RHO GTPase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 109 Back     alignment and structure
>1l7b_A DNA ligase; BRCT, autostructure, structural genomics, NESG, PSI, protein structure initiative, northeast structural genomics consortium; HET: DNA; NMR {Thermus thermophilus} SCOP: c.15.1.2 Length = 92 Back     alignment and structure
>1wf6_A Similar to S.pombe -RAD4+/CUT5+product (A40727); BRCT, topoisomerase II binding protein, checkpoint; NMR {Homo sapiens} SCOP: c.15.1.5 Length = 132 Back     alignment and structure
>1t15_A Breast cancer type 1 susceptibility protein; protein-peptide complex, antitumor protein; HET: SEP; 1.85A {Homo sapiens} SCOP: c.15.1.3 c.15.1.3 PDB: 1jnx_X* 1t29_A* 1t2v_A* 1y98_A* 3coj_X* 3k0h_A* 3k0k_A* 3pxe_A* 3pxb_A 3pxc_X 1t2u_A 1n5o_X 3pxa_A 3k15_A* 3k16_A* 3pxd_A 2ing_X 1oqa_A Length = 214 Back     alignment and structure
>1t15_A Breast cancer type 1 susceptibility protein; protein-peptide complex, antitumor protein; HET: SEP; 1.85A {Homo sapiens} SCOP: c.15.1.3 c.15.1.3 PDB: 1jnx_X* 1t29_A* 1t2v_A* 1y98_A* 3coj_X* 3k0h_A* 3k0k_A* 3pxe_A* 3pxb_A 3pxc_X 1t2u_A 1n5o_X 3pxa_A 3k15_A* 3k16_A* 3pxd_A 2ing_X 1oqa_A Length = 214 Back     alignment and structure
>1l0b_A BRCA1; TANDEM-BRCT, three-helix bundle, unknown function; 2.30A {Rattus norvegicus} SCOP: c.15.1.3 c.15.1.3 Length = 229 Back     alignment and structure
>1z56_C DNA ligase IV; DNA repair, BRCT, NHEJ, XRCC4, DNA ligase, coiled-coil; HET: DNA; 3.92A {Saccharomyces cerevisiae} Length = 264 Back     alignment and structure
>3ii6_X DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alternative splicing, coiled coil, DNA damage, DNA recombination, isopeptide bond, nucleus; HET: DNA; 2.40A {Homo sapiens} PDB: 2e2w_A* Length = 263 Back     alignment and structure
>3ii6_X DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alternative splicing, coiled coil, DNA damage, DNA recombination, isopeptide bond, nucleus; HET: DNA; 2.40A {Homo sapiens} PDB: 2e2w_A* Length = 263 Back     alignment and structure
>2etx_A Mediator of DNA damage checkpoint protein 1; tandem BRCT domains histone gamma-H2AX, cell cycle; 1.33A {Homo sapiens} PDB: 2azm_A* 3k05_A* 2ado_A Length = 209 Back     alignment and structure
>2etx_A Mediator of DNA damage checkpoint protein 1; tandem BRCT domains histone gamma-H2AX, cell cycle; 1.33A {Homo sapiens} PDB: 2azm_A* 3k05_A* 2ado_A Length = 209 Back     alignment and structure
>3u3z_A Microcephalin; DNA repair, cell cycle regulation, cell cycle; HET: SEP PTR; 1.50A {Homo sapiens} PDB: 3szm_A* 3t1n_A* 3sht_A 3shv_A* Length = 199 Back     alignment and structure
>3l41_A BRCT-containing protein 1; BRC1, BRCT domain, tandem BRCT repeat, phosphoserine binding domain, DNA repair, cell division, mitosis; HET: SEP; 1.45A {Schizosaccharomyces pombe} PDB: 3l40_A* Length = 220 Back     alignment and structure
>1dgs_A DNA ligase; AMP complex, NAD+-dependent; HET: DNA AMP; 2.90A {Thermus filiformis} SCOP: a.60.2.2 b.40.4.6 d.142.2.2 PDB: 1v9p_A* Length = 667 Back     alignment and structure
>2ebu_A Replication factor C subunit 1; A/B/A 3 layers, parallel beta-sheet, DNA replication, clamp loader, RFC1, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 112 Back     alignment and structure
>2k6g_A Replication factor C subunit 1; protein, BRCT, DNA binding, activator, alternative splicing, ATP-binding, DNA replication, DNA- binding; NMR {Homo sapiens} PDB: 2k7f_A Length = 109 Back     alignment and structure
>1kzy_C Tumor suppressor P53-binding protein 1; tandem-BRCT and linker complexed with non-BRCT protein, three-helix bundle, parallel beta sheet; 2.50A {Homo sapiens} SCOP: c.15.1.4 c.15.1.4 PDB: 1gzh_B Length = 259 Back     alignment and structure
>3al2_A DNA topoisomerase 2-binding protein 1; BRCT domain, protein binding, DNA binding protein; HET: DNA MSE; 2.00A {Homo sapiens} PDB: 3al3_A* Length = 235 Back     alignment and structure
>3al2_A DNA topoisomerase 2-binding protein 1; BRCT domain, protein binding, DNA binding protein; HET: DNA MSE; 2.00A {Homo sapiens} PDB: 3al3_A* Length = 235 Back     alignment and structure
>2nte_A BARD-1, BRCA1-associated ring domain protein 1; BRCT, ring finger, zinc-binding protein, ubiquitin LI antitumor protein; 1.90A {Homo sapiens} PDB: 3fa2_A 2r1z_A Length = 210 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query815
4dqy_C506 Poly [ADP-ribose] polymerase 1; PARP, poly(ADP-rib 100.0
3kjd_A368 Poly [ADP-ribose] polymerase 2; transferase, enzym 100.0
1efy_A350 Poly (ADP-ribose) polymerase; benzimidazole, inhib 100.0
3c4h_A357 Poly(ADP-ribose) polymerase 3; enzyme-inhibitor co 100.0
2riq_A160 Poly [ADP-ribose] polymerase 1; Zn-binding domain, 100.0
2x5y_A173 Zinc finger CCCH-type antiviral protein 1; antivir 100.0
3u9h_A240 Tankyrase-2; protein-ligand complex, diphtheria to 100.0
2pqf_A198 Poly [ADP-ribose] polymerase 12; enzyme-inhibitor 100.0
3blj_A221 Poly(ADP-ribose) polymerase 15; PARP, BAL-3, SGC, 100.0
3hkv_A217 PARP-10, poly [ADP-ribose] polymerase 10; NAD, tra 100.0
3smj_A193 Poly [ADP-ribose] polymerase 14; diphtheria toxin 100.0
2eoc_A124 Poly [ADP-ribose] polymerase 3; anti-parallel beta 99.97
4f0d_A277 PARP-16, poly [ADP-ribose] polymerase 16; transfer 99.83
2cok_A113 Poly [ADP-ribose] polymerase-1; BRCT domain, DNA r 99.64
3l3e_A107 DNA topoisomerase 2-binding protein 1; BRCT domain 99.63
2d8m_A129 DNA-repair protein XRCC1; parallel beta-sheet, DNA 99.61
3l46_A112 Protein ECT2; alternative splicing, guanine-nucleo 99.51
1l7b_A92 DNA ligase; BRCT, autostructure, structural genomi 99.51
2k6g_A109 Replication factor C subunit 1; protein, BRCT, DNA 99.47
2ebu_A112 Replication factor C subunit 1; A/B/A 3 layers, pa 99.45
2cou_A109 ECT2 protein; BRCT domain, RHO GTPase, structural 99.41
4id3_A92 DNA repair protein REV1; BRCT domain, protein bind 99.36
2ebw_A97 DNA repair protein REV1; A/B/A 3 layers, parallel 99.33
3olc_X298 DNA topoisomerase 2-binding protein 1; BRCT domain 99.26
3ef1_A442 RNA polymerase II subunit A C-terminal domain phos 99.22
3ef0_A372 RNA polymerase II subunit A C-terminal domain phos 99.21
3pa6_A107 Microcephalin; BRCT domain, cell cycle; HET: MSE; 99.2
1wf6_A132 Similar to S.pombe -RAD4+/CUT5+product (A40727); B 99.06
3pc6_A104 DNA repair protein XRCC1; BRCT domain, protein:pro 98.99
3olc_X298 DNA topoisomerase 2-binding protein 1; BRCT domain 98.93
1kzy_C259 Tumor suppressor P53-binding protein 1; tandem-BRC 98.9
3sqd_A219 PAX-interacting protein 1; tandem BRCT domains, ce 98.87
3ii6_X263 DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alter 98.84
2vxb_A241 DNA repair protein RHP9; BRCT, nucleus, cell cycle 98.83
1l0b_A229 BRCA1; TANDEM-BRCT, three-helix bundle, unknown fu 98.83
1t15_A214 Breast cancer type 1 susceptibility protein; prote 98.78
2nte_A210 BARD-1, BRCA1-associated ring domain protein 1; BR 98.77
1dgs_A667 DNA ligase; AMP complex, NAD+-dependent; HET: DNA 98.77
2owo_A671 DNA ligase; protein-DNA complex, ligase-DNA comple 98.75
3al2_A235 DNA topoisomerase 2-binding protein 1; BRCT domain 98.73
2etx_A209 Mediator of DNA damage checkpoint protein 1; tande 98.68
3u3z_A199 Microcephalin; DNA repair, cell cycle regulation, 98.59
3l41_A220 BRCT-containing protein 1; BRC1, BRCT domain, tand 98.33
3u3z_A199 Microcephalin; DNA repair, cell cycle regulation, 98.32
1t15_A214 Breast cancer type 1 susceptibility protein; prote 98.29
2ep8_A100 Pescadillo homolog 1; A/B/A 3 layers, nucleolus, r 98.29
1z56_C264 DNA ligase IV; DNA repair, BRCT, NHEJ, XRCC4, DNA 98.29
1l0b_A229 BRCA1; TANDEM-BRCT, three-helix bundle, unknown fu 98.24
3ii6_X263 DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alter 98.11
2etx_A209 Mediator of DNA damage checkpoint protein 1; tande 97.99
2jw5_A106 DNA polymerase lambda; BRCT domain, family X polym 97.91
3pc7_A88 DNA ligase 3; DNA repair, BRCT domain, protein:pro 97.82
1z56_C264 DNA ligase IV; DNA repair, BRCT, NHEJ, XRCC4, DNA 97.8
2nte_A210 BARD-1, BRCA1-associated ring domain protein 1; BR 97.7
3sqd_A219 PAX-interacting protein 1; tandem BRCT domains, ce 97.68
2coe_A120 Deoxynucleotidyltransferase, terminal variant; BRC 97.59
1kzy_C259 Tumor suppressor P53-binding protein 1; tandem-BRC 97.58
2dun_A133 POL MU, DNA polymerase MU; layers A/B/A, parallel 97.18
3al2_A235 DNA topoisomerase 2-binding protein 1; BRCT domain 96.84
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 96.76
2l42_A106 DNA-binding protein RAP1; BRCT domain, protein bin 96.67
3l41_A220 BRCT-containing protein 1; BRC1, BRCT domain, tand 95.72
2vxb_A241 DNA repair protein RHP9; BRCT, nucleus, cell cycle 95.43
4gns_A290 Chitin biosynthesis protein CHS5; FN3, BRCT, tetra 92.9
3huf_A325 DNA repair and telomere maintenance protein NBS1; 91.97
3t7k_A256 RTT107, regulator of TY1 transposition protein 107 81.18
>4dqy_C Poly [ADP-ribose] polymerase 1; PARP, poly(ADP-ribose) polymerase, DNA binding protein, ADP- transferase, PARP-like zinc finger, poly(ADP-ribosyl)ation; HET: DNA; 3.25A {Homo sapiens} PDB: 2cr9_A Back     alignment and structure
Probab=100.00  E-value=4.5e-125  Score=1073.88  Aligned_cols=486  Identities=30%  Similarity=0.520  Sum_probs=431.2

Q ss_pred             HHHHHHHHhcCccCCCCCccccCCceEEEeCCeEEEEEEeeecCCCCcccEEEEEEEEcCC-CCeEEEEEeeccCCCCcc
Q 037230          302 SIAAELKLYGKRGVYKDTKLQEQGGKILEKDGILYNCAFSLCDQGRGMNLYCIVQLITVPD-SNLHLYYKKGKVGDDPNA  380 (815)
Q Consensus       302 s~~~k~k~kg~~~Vd~~s~l~~~~~hVy~d~~~~Y~~~L~~tDi~~~~NkfY~lQlle~~~-~~y~vf~~wGRVG~~~~g  380 (815)
                      ++++++++||+++|||+|++.+ ++|||+++|.+|+|+|+++|+++|+|+||+|||++++. +.|+||++|||||+.+ |
T Consensus         4 ~~~~~~~~kg~~~Vd~~~~~~~-~~~Vy~~~~~~Y~~~L~~td~~~n~NkfY~lQll~~~~~~~y~v~~rWGRVG~~~-G   81 (506)
T 4dqy_C            4 EKRMKLTLKGGAAVDPDSGLEH-SAHVLEKGGKVFSATLGLVDIVKGTNSYYKLQLLEDDKENRYWIFRSWGRVGTVI-G   81 (506)
T ss_dssp             -----------CCCCGGGSCTT-TSCCCEETTEESEEEEEEECTTTCCEEEEEEECC--------CEEEEEEETTSSC-E
T ss_pred             CceEEEEEeCCeecCCccCCCC-ceEEEEeCCeEEEEEEEcccccCCCcceEEEEEEEcCCCCEEEEEEEECccCccc-c
Confidence            3578899999999999999986 99999999999999999999999999999999999876 8899999999999964 7


Q ss_pred             cccccCCCCHHHHHHHHHHHHHHHhcCCCccccccccCccCCCCccccccCCccccccCCCCcccccccCCCCCCCHHHH
Q 037230          381 EERLEEWTGVDNAIKEFVRLFEEVTGNEFEPWEREKKFQKKPLKFYPIDMDDGVEVRHGGLGMRQLGVAAAHSKLDPVVA  460 (815)
Q Consensus       381 ~~k~~~~~s~e~Ai~~F~k~F~eKTgn~w~~w~~r~~f~k~pgKy~~v~~d~~~~~~~~~~~~~~~~~~~~~s~L~~~Vq  460 (815)
                      ++++++|+++++|+++|+++|++||||+|   ++| +|+++||||+||++||+.+++... .+.  .....+|+|+++||
T Consensus        82 q~~l~~~~s~~~Ai~~F~k~F~~KTgn~W---~~R-~f~k~pgKy~~ve~d~~~~~~~~~-~~~--~~~~~~s~L~~~Vq  154 (506)
T 4dqy_C           82 SNKLEQMPSKEDAIEHFMKLYEEKTGNAW---HSK-NFTKYPKKFYPLEIDYGQDEEAVK-KLT--VNPGTKSKLPKPVQ  154 (506)
T ss_dssp             EEEEECCSCSHHHHHHHHHHHHHHHSSCS---SCS-SCCCCTTCCEEECBC--------------------CCCSCHHHH
T ss_pred             cceeccCCCHHHHHHHHHHHHHHHhcCCc---ccc-CccccCCccceeecccccchhhhh-hhc--ccCCCCCCCCHHHH
Confidence            89999999999999999999999999965   778 999999999999999986433211 111  12457899999999


Q ss_pred             HHHHHHhCHHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcccccchhhHHHHHHhhhhccccccCC--
Q 037230          461 NFMKVLCSQEVYRYALMEMGLDAPDLPIGMLSNVHLNRCEEVLQQFIEAVKSTKETGQKAEAIWTDFSNRWFTLMHSL--  538 (815)
Q Consensus       461 ~Li~~I~d~~~~~~~~~e~~~d~~k~PLGkLS~~qI~~a~~vL~ei~~~l~~~~~~~~~~~~~l~~lsn~fYtlIPh~--  538 (815)
                      +||++|||+++|+++|++|++|+.+||||+||++||.+||+||.+|+++|++..     ..+.+.+|||+|||+|||+  
T Consensus       155 ~Li~lIfd~~~~~~~m~~~~~D~~k~PLGkLS~~qI~~g~~vL~~i~~~l~~~~-----~~~~l~~lsn~fYtlIPh~fg  229 (506)
T 4dqy_C          155 DLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGS-----SDSQILDLSNRFYTLIPHDFG  229 (506)
T ss_dssp             HHHHHHSCHHHHHHHHHTTTBCCSSTTTSCBCHHHHHHHHHHHHHHHHHHHTTC-----CHHHHHHHHHHHHHHSCBCCT
T ss_pred             HHHHHHhHHHHHHHHHHHhCCChhhCCCccCCHHHHHHHHHHHHHHHHHHhccc-----cHHHHHHHHhhhhEeCCcccc
Confidence            999999999999999999999999999999999999999999999999998653     3468999999999999997  


Q ss_pred             --CCccCCCHHHHHHHHHHHHHHHHHHHHHHHhhhcccCCCCCCcchhhhhhcCceeEEcCCCCHHHHHHHHHHHhccCC
Q 037230          539 --RPFIFRDNQEIADHAASSFEAVRDITVASHLIGDMSGSTLDDPLSDCYEKLACSISALEKDSDDYKMIVNYLEKTYEP  616 (815)
Q Consensus       539 --~p~~i~~~~~l~~k~~~lle~L~die~A~~ll~~~~~~~~~~pld~~Y~~L~~~i~~L~~~s~ey~~I~~y~~~t~~~  616 (815)
                        +||+|++.++|++|+ +||++|.||++|++|+++.......||+|.+|++|+|+|++|+++|+||++|++||++|+++
T Consensus       230 ~~~pp~i~~~~~l~~k~-~ll~~L~dieiA~~l~~~~~~~~~~~pld~~Y~~L~~~l~~L~~~s~Ey~~I~~~~~~T~~~  308 (506)
T 4dqy_C          230 MKKPPLLNNADSVQAKA-EMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHAT  308 (506)
T ss_dssp             TSCCCCCCSHHHHHHHH-HHHHHHHHHHHHHHHHSCSCCCTTSCHHHHHHHHTCEEEEECCTTCHHHHHHHHHHHHTCCS
T ss_pred             CCCCCccCCHHHHHHHH-HHHHHHHHHHHHHHHHhhhccCCCCCchHHHHHHhCcEEEECCCCChHHHHHHHHHHhccCc
Confidence              899999999999999 99999999999999997643446789999999999999999999999999999999999999


Q ss_pred             CccCCcccccccceeeeEecCC-ccchhhhhcCCCceeeeccCCccchhhhcccCCCCCCCCCCCCCceeeeeeeechhh
Q 037230          617 VKLGDIEYGVSVDNIFVIESNA-QPSLDEIKKLPNKVLLWCGTRSSNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAA  695 (815)
Q Consensus       617 ~h~~~~~~~~~I~~If~v~r~~-~~~f~~~~~~~N~~lLwHGSr~~N~~gIL~~Gl~iap~~a~~tG~mFGkGIYFAd~~  695 (815)
                      +|   ..|+++|++||||+|++ +++|+++++++|+++||||||.+||++||++||+++|++++.+|+|||+|||||+++
T Consensus       309 ~h---~~~~~~I~~I~rI~~~~e~~~f~~~k~~~N~~lL~HGT~~~n~~~Il~~Gf~~~~~~a~~~G~~fGkGiYFA~~a  385 (506)
T 4dqy_C          309 TH---NAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMV  385 (506)
T ss_dssp             SC---TTCCCCEEEEEEEEETTTTTTTHHHHSSSCEEEEEEECCTTTHHHHHHHCSCCCCSSSCCTTCSSCSSEEEBSSH
T ss_pred             cc---ccCCceeEeEEEEccHHHHhhHHHhhcCCCceEEecCCChHhHHHHHhcCCCcCCccCCcCCceeeeeEEecchh
Confidence            99   67899999999999999 999999989999999999999999999999999999999999999999999999999


Q ss_pred             hhhhcccccCCCCCceEEEEEEEecCCcceeccCCCCcCccCCCCCcceeeeccccCCCCCceeecCCeEecCCCcccCC
Q 037230          696 AEAARYGFTAADRPEGFLVLAVASLGDQVTELKKPPEDTKSLEDKKLGVKGLGRKKTDESEHFFWNDDIKVPGGRLIPSE  775 (815)
Q Consensus       696 skS~~Yc~~~~~~~~~~mlLceVaLG~~~~e~~~~~~~~~~~p~G~~Sv~g~G~~~Pdp~~~~~~~dgv~vP~G~~~~~~  775 (815)
                      |||++||+++..++.++||||+||||+ ++++..+ .++++||+|||||+|+|++.|||++. ++.|||.||+|+++++.
T Consensus       386 skS~~Y~~~~~~~~~~~mll~~V~lG~-~~~~~~~-~~~~~~p~G~dSv~g~g~~~P~p~~~-~~~dGv~vP~G~~~~~~  462 (506)
T 4dqy_C          386 SKSANYCHTSQGDPIGLILLGEVALGN-MYELKHA-SHISKLPKGKHSVKGLGKTTPDPSAN-ISLDGVDVPLGTGISSG  462 (506)
T ss_dssp             HHHHTTSCCCSSSCEEEEEEEEEECCS-EEEESSC-CCCSSCCTTCCEEEECCSEEECGGGC-EESSSCEECCCCEEECS
T ss_pred             hccccccCCCCCCCeEEEEEEEEecCC-ceecccc-hhhhccCCCCceEEeCCcCcCCcccc-cccCCeEEECCCcccCC
Confidence            999999999877889999999999999 9999988 57999999999999999999999998 88999999999999988


Q ss_pred             CCCCCCCCceEEEecCCCcceeeEEEEEecccc
Q 037230          776 HKNSPLEYNEYAVYDPKQTSIRFLVGVKFEERG  808 (815)
Q Consensus       776 ~~~~~l~ynEyIVYd~~Qv~~rYLv~~~~~~~~  808 (815)
                      ..+++|.||||||||++||||||||+|+|+|+.
T Consensus       463 ~~~~~l~ynEyiVYd~~Qir~rYLv~v~~~~~~  495 (506)
T 4dqy_C          463 VNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT  495 (506)
T ss_dssp             CCCCSCSBCEEEESSGGGEEEEEEEEEECCCCC
T ss_pred             CCCCcccccceEEEchHHeeEEEEEEEEEEcch
Confidence            888999999999999999999999999999986



>3kjd_A Poly [ADP-ribose] polymerase 2; transferase, enzyme-inhibitor complex, catalytic fragment, S genomics, structural genomics consortium, SGC; HET: 78P; 1.95A {Homo sapiens} PDB: 3kcz_A* 1gs0_A Back     alignment and structure
>1efy_A Poly (ADP-ribose) polymerase; benzimidazole, inhibitor, catalytic fragment, transferase; HET: BZC; 2.20A {Gallus gallus} SCOP: a.41.1.1 d.166.1.2 PDB: 1a26_A* 1pax_A* 2paw_A 2pax_A* 3pax_A* 4pax_A* 2rcw_A* 1uk1_A* 1wok_A* 1uk0_A* 2rd6_A* 3gjw_A* 3gn7_A* 3l3l_A* 3l3m_A* Back     alignment and structure
>3c4h_A Poly(ADP-ribose) polymerase 3; enzyme-inhibitor complex, catalytic fragment, structural GEN structural genomics consortium, SGC; HET: DRL; 2.10A {Homo sapiens} PDB: 3c49_A* 2pa9_A* 3ce0_A* 3fhb_A* Back     alignment and structure
>2riq_A Poly [ADP-ribose] polymerase 1; Zn-binding domain, Zn ribbon, Zn finger, ADP-ribosylation, D damage, DNA repair, DNA-binding, glycosyltransferase; 1.70A {Homo sapiens} PDB: 2jvn_A Back     alignment and structure
>2x5y_A Zinc finger CCCH-type antiviral protein 1; antiviral defense, immune system, transferase; 1.05A {Homo sapiens} Back     alignment and structure
>3u9h_A Tankyrase-2; protein-ligand complex, diphtheria toxin like fold, transfer ribosylation; HET: SO4; 1.75A {Homo sapiens} PDB: 3kr8_A* 3kr7_A* 3p0n_A* 3p0p_A* 3p0q_A* 3mhj_A* 3u9y_A* 3ua9_A* 4avu_A* 4avw_A* 3mhk_A* 2rf5_A 3udd_A* 3uh2_A* 3uh4_A* 4dvi_A* 4hlh_A* 4hki_A* 4hkn_A* 4hl5_A* ... Back     alignment and structure
>2pqf_A Poly [ADP-ribose] polymerase 12; enzyme-inhibitor complex, catalytic fragment, structural GEN structural genomics consortium, SGC, transferase; HET: GAB CIT; 2.20A {Homo sapiens} Back     alignment and structure
>3blj_A Poly(ADP-ribose) polymerase 15; PARP, BAL-3, SGC, structural GE consortium, glycosyltransferase, NAD, nucleus; 2.20A {Homo sapiens} PDB: 3gey_A* Back     alignment and structure
>3hkv_A PARP-10, poly [ADP-ribose] polymerase 10; NAD, transferase, structural genomics, structural genomics consortium, SGC, cytoplasm, glycosyltransferase; HET: 3AB; 2.10A {Homo sapiens} Back     alignment and structure
>3smj_A Poly [ADP-ribose] polymerase 14; diphtheria toxin like fold, transferase, NAD+, ADP-ribosylat transferase-transferase inhibitor complex; HET: FDR; 1.50A {Homo sapiens} PDB: 3goy_A* 3smi_A* 3se2_A* 4f1l_A* 4f1q_A* Back     alignment and structure
>2eoc_A Poly [ADP-ribose] polymerase 3; anti-parallel beta-sheet, cell cycle control, DNA damage, transcription, NAD+, structural genomics, NPPSFA; NMR {Homo sapiens} Back     alignment and structure
>4f0d_A PARP-16, poly [ADP-ribose] polymerase 16; transferase, ARTD15, structural genomics structural genomics consortium, SGC; HET: 3AB; 2.70A {Homo sapiens} Back     alignment and structure
>2cok_A Poly [ADP-ribose] polymerase-1; BRCT domain, DNA repair, structural genomics, NPPSFA; NMR {Homo sapiens} PDB: 2le0_A Back     alignment and structure
>2d8m_A DNA-repair protein XRCC1; parallel beta-sheet, DNA ligase III, poly(ADP-ribose) polymerase-1, DNA polymerase beta, structural genomics, NPPSFA; NMR {Homo sapiens} Back     alignment and structure
>3l46_A Protein ECT2; alternative splicing, guanine-nucleotide releasing factor, phosphoprotein, polymorphism, proto-oncogene, structural genomics; 1.48A {Homo sapiens} Back     alignment and structure
>1l7b_A DNA ligase; BRCT, autostructure, structural genomics, NESG, PSI, protein structure initiative, northeast structural genomics consortium; HET: DNA; NMR {Thermus thermophilus} SCOP: c.15.1.2 Back     alignment and structure
>2k6g_A Replication factor C subunit 1; protein, BRCT, DNA binding, activator, alternative splicing, ATP-binding, DNA replication, DNA- binding; NMR {Homo sapiens} PDB: 2k7f_A Back     alignment and structure
>2ebu_A Replication factor C subunit 1; A/B/A 3 layers, parallel beta-sheet, DNA replication, clamp loader, RFC1, structural genomics, NPPSFA; NMR {Homo sapiens} Back     alignment and structure
>2cou_A ECT2 protein; BRCT domain, RHO GTPase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Back     alignment and structure
>4id3_A DNA repair protein REV1; BRCT domain, protein binding; HET: DNA; 1.97A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>2ebw_A DNA repair protein REV1; A/B/A 3 layers, parallel beta-sheet, DNA replication, translession synthesis, TLS, DNA polymerase zeta, PCNA; HET: DNA; NMR {Homo sapiens} Back     alignment and structure
>3olc_X DNA topoisomerase 2-binding protein 1; BRCT domain, DNA repair, RAD9, DNA binding protein; HET: DNA; 2.40A {Homo sapiens} PDB: 2xnk_A* 2xnh_A* Back     alignment and structure
>3ef1_A RNA polymerase II subunit A C-terminal domain phosphatase; CTD, FCPH, BRCT, hydrolase, BEF3, acylphosphate analog, cobalt, magnesium; HET: BFD; 2.15A {Schizosaccharomyces pombe} Back     alignment and structure
>3ef0_A RNA polymerase II subunit A C-terminal domain phosphatase; CTD, FCPH, BRCT, hydrolase, ALF4, transition state analog, cobalt, magnesium; 2.10A {Schizosaccharomyces pombe} Back     alignment and structure
>3pa6_A Microcephalin; BRCT domain, cell cycle; HET: MSE; 1.50A {Homo sapiens} PDB: 3ktf_A* 2wt8_A* Back     alignment and structure
>1wf6_A Similar to S.pombe -RAD4+/CUT5+product (A40727); BRCT, topoisomerase II binding protein, checkpoint; NMR {Homo sapiens} SCOP: c.15.1.5 Back     alignment and structure
>3pc6_A DNA repair protein XRCC1; BRCT domain, protein:protein interactions, DNA L III-alpha BRCT2 domain, DNA binding protein; HET: DNA; 1.90A {Mus musculus} SCOP: c.15.1.1 PDB: 3pc8_A* 3qvg_B* 1cdz_A Back     alignment and structure
>3olc_X DNA topoisomerase 2-binding protein 1; BRCT domain, DNA repair, RAD9, DNA binding protein; HET: DNA; 2.40A {Homo sapiens} PDB: 2xnk_A* 2xnh_A* Back     alignment and structure
>1kzy_C Tumor suppressor P53-binding protein 1; tandem-BRCT and linker complexed with non-BRCT protein, three-helix bundle, parallel beta sheet; 2.50A {Homo sapiens} SCOP: c.15.1.4 c.15.1.4 PDB: 1gzh_B Back     alignment and structure
>3sqd_A PAX-interacting protein 1; tandem BRCT domains, cell cycle; HET: SEP; 2.15A {Homo sapiens} Back     alignment and structure
>3ii6_X DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alternative splicing, coiled coil, DNA damage, DNA recombination, isopeptide bond, nucleus; HET: DNA; 2.40A {Homo sapiens} PDB: 2e2w_A* Back     alignment and structure
>2vxb_A DNA repair protein RHP9; BRCT, nucleus, cell cycle, DNA damage, DNA replication inhibitor, phosphoprotein, checkpoint signalling; HET: DNA; 2.3A {Schizosaccharomyces pombe} PDB: 2vxc_A* Back     alignment and structure
>1l0b_A BRCA1; TANDEM-BRCT, three-helix bundle, unknown function; 2.30A {Rattus norvegicus} SCOP: c.15.1.3 c.15.1.3 Back     alignment and structure
>1t15_A Breast cancer type 1 susceptibility protein; protein-peptide complex, antitumor protein; HET: SEP; 1.85A {Homo sapiens} SCOP: c.15.1.3 c.15.1.3 PDB: 1jnx_X* 1t29_A* 1t2v_A* 1y98_A* 3coj_X* 3k0h_A* 3k0k_A* 3pxe_A* 3pxb_A 3pxc_X 1t2u_A 1n5o_X 3pxa_A 3k15_A* 3k16_A* 3pxd_A 2ing_X 1oqa_A Back     alignment and structure
>2nte_A BARD-1, BRCA1-associated ring domain protein 1; BRCT, ring finger, zinc-binding protein, ubiquitin LI antitumor protein; 1.90A {Homo sapiens} PDB: 3fa2_A 2r1z_A Back     alignment and structure
>1dgs_A DNA ligase; AMP complex, NAD+-dependent; HET: DNA AMP; 2.90A {Thermus filiformis} SCOP: a.60.2.2 b.40.4.6 d.142.2.2 PDB: 1v9p_A* Back     alignment and structure
>2owo_A DNA ligase; protein-DNA complex, ligase-DNA complex; HET: DNA OMC AMP; 2.30A {Escherichia coli} Back     alignment and structure
>3al2_A DNA topoisomerase 2-binding protein 1; BRCT domain, protein binding, DNA binding protein; HET: DNA MSE; 2.00A {Homo sapiens} PDB: 3al3_A* Back     alignment and structure
>2etx_A Mediator of DNA damage checkpoint protein 1; tandem BRCT domains histone gamma-H2AX, cell cycle; 1.33A {Homo sapiens} PDB: 2azm_A* 3k05_A* 2ado_A Back     alignment and structure
>3u3z_A Microcephalin; DNA repair, cell cycle regulation, cell cycle; HET: SEP PTR; 1.50A {Homo sapiens} PDB: 3szm_A* 3t1n_A* 3sht_A 3shv_A* Back     alignment and structure
>3l41_A BRCT-containing protein 1; BRC1, BRCT domain, tandem BRCT repeat, phosphoserine binding domain, DNA repair, cell division, mitosis; HET: SEP; 1.45A {Schizosaccharomyces pombe} PDB: 3l40_A* Back     alignment and structure
>3u3z_A Microcephalin; DNA repair, cell cycle regulation, cell cycle; HET: SEP PTR; 1.50A {Homo sapiens} PDB: 3szm_A* 3t1n_A* 3sht_A 3shv_A* Back     alignment and structure
>1t15_A Breast cancer type 1 susceptibility protein; protein-peptide complex, antitumor protein; HET: SEP; 1.85A {Homo sapiens} SCOP: c.15.1.3 c.15.1.3 PDB: 1jnx_X* 1t29_A* 1t2v_A* 1y98_A* 3coj_X* 3k0h_A* 3k0k_A* 3pxe_A* 3pxb_A 3pxc_X 1t2u_A 1n5o_X 3pxa_A 3k15_A* 3k16_A* 3pxd_A 2ing_X 1oqa_A Back     alignment and structure
>2ep8_A Pescadillo homolog 1; A/B/A 3 layers, nucleolus, ribosome biogenesis, DNA damage, structural genomics, NPPSFA; NMR {Homo sapiens} Back     alignment and structure
>1z56_C DNA ligase IV; DNA repair, BRCT, NHEJ, XRCC4, DNA ligase, coiled-coil; HET: DNA; 3.92A {Saccharomyces cerevisiae} Back     alignment and structure
>1l0b_A BRCA1; TANDEM-BRCT, three-helix bundle, unknown function; 2.30A {Rattus norvegicus} SCOP: c.15.1.3 c.15.1.3 Back     alignment and structure
>3ii6_X DNA ligase 4; XRCC4, NHEJ, DNA repair, BRCT, alternative splicing, coiled coil, DNA damage, DNA recombination, isopeptide bond, nucleus; HET: DNA; 2.40A {Homo sapiens} PDB: 2e2w_A* Back     alignment and structure
>2etx_A Mediator of DNA damage checkpoint protein 1; tandem BRCT domains histone gamma-H2AX, cell cycle; 1.33A {Homo sapiens} PDB: 2azm_A* 3k05_A* 2ado_A Back     alignment and structure
>2jw5_A DNA polymerase lambda; BRCT domain, family X polymerase, nonhomologous END joining (NHEJ), DNA damage, DNA repair, DNA replication, DNA synthesis; HET: DNA; NMR {Homo sapiens} Back     alignment and structure
>3pc7_A DNA ligase 3; DNA repair, BRCT domain, protein:protein interactions, XRCC1 domain, DNA binding protein; HET: DNA MSE; 1.65A {Homo sapiens} SCOP: c.15.1.2 PDB: 3pc8_C* 1imo_A* 1in1_A* 3qvg_A* Back     alignment and structure
>1z56_C DNA ligase IV; DNA repair, BRCT, NHEJ, XRCC4, DNA ligase, coiled-coil; HET: DNA; 3.92A {Saccharomyces cerevisiae} Back     alignment and structure
>2nte_A BARD-1, BRCA1-associated ring domain protein 1; BRCT, ring finger, zinc-binding protein, ubiquitin LI antitumor protein; 1.90A {Homo sapiens} PDB: 3fa2_A 2r1z_A Back     alignment and structure
>3sqd_A PAX-interacting protein 1; tandem BRCT domains, cell cycle; HET: SEP; 2.15A {Homo sapiens} Back     alignment and structure
>2coe_A Deoxynucleotidyltransferase, terminal variant; BRCT domain, DNA polymerase, teminal deoxynucleotidyltransferase, structural genomics, NPPSFA; NMR {Homo sapiens} Back     alignment and structure
>1kzy_C Tumor suppressor P53-binding protein 1; tandem-BRCT and linker complexed with non-BRCT protein, three-helix bundle, parallel beta sheet; 2.50A {Homo sapiens} SCOP: c.15.1.4 c.15.1.4 PDB: 1gzh_B Back     alignment and structure
>2dun_A POL MU, DNA polymerase MU; layers A/B/A, parallel beta-sheet of 4 strands, non- homologous END jonting, somatic hypermutation, V(D)J recombination; HET: DNA; NMR {Homo sapiens} PDB: 2htf_A* Back     alignment and structure
>3al2_A DNA topoisomerase 2-binding protein 1; BRCT domain, protein binding, DNA binding protein; HET: DNA MSE; 2.00A {Homo sapiens} PDB: 3al3_A* Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>2l42_A DNA-binding protein RAP1; BRCT domain, protein binding; NMR {Saccharomyces cerevisiae} Back     alignment and structure
>3l41_A BRCT-containing protein 1; BRC1, BRCT domain, tandem BRCT repeat, phosphoserine binding domain, DNA repair, cell division, mitosis; HET: SEP; 1.45A {Schizosaccharomyces pombe} PDB: 3l40_A* Back     alignment and structure
>2vxb_A DNA repair protein RHP9; BRCT, nucleus, cell cycle, DNA damage, DNA replication inhibitor, phosphoprotein, checkpoint signalling; HET: DNA; 2.3A {Schizosaccharomyces pombe} PDB: 2vxc_A* Back     alignment and structure
>4gns_A Chitin biosynthesis protein CHS5; FN3, BRCT, tetratricopeptide repeat, cargo adaptor, transpor; HET: EPE; 2.75A {Saccharomyces cerevisiae} Back     alignment and structure
>3huf_A DNA repair and telomere maintenance protein NBS1; NBS1, FHA domain, BRCT domain, phosphoprotein binding, phosp binding, DNA repair; HET: DNA TPO; 2.15A {Schizosaccharomyces pombe} PDB: 3hue_A* 3i0m_A* 3i0n_A* Back     alignment and structure
>3t7k_A RTT107, regulator of TY1 transposition protein 107; BRCT, DNA repair, phospho-peptide, protein binding; HET: SEP; 2.03A {Saccharomyces cerevisiae} PDB: 3t7j_A* 3t7i_A Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 815
d1efya2215 d.166.1.2 (A:797-1011) Poly(ADP-ribose) polymerase 2e-50
d1gs0a2217 d.166.1.2 (A:341-557) Poly(ADP-ribose) polymerase, 4e-50
d1efya1135 a.41.1.1 (A:662-796) Domain of poly(ADP-ribose) po 1e-32
d1gs0a1134 a.41.1.1 (A:207-340) Domain of poly(ADP-ribose) po 2e-29
d2cr9a1126 d.297.1.1 (A:8-133) Poly [ADP-ribose] polymerase-1 7e-29
d1l7ba_92 c.15.1.2 (A:) NAD+-dependent DNA ligase, domain 4 6e-11
d1kzyc1153 c.15.1.4 (C:1714-1866) 53BP1 {Human (Homo sapiens) 6e-08
d1t15a2102 c.15.1.3 (A:1758-1859) Breast cancer associated pr 5e-06
d1wf6a_132 c.15.1.5 (A:) DNA topoisomerase II binding protein 2e-05
>d1efya2 d.166.1.2 (A:797-1011) Poly(ADP-ribose) polymerase, C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 215 Back     information, alignment and structure

class: Alpha and beta proteins (a+b)
fold: ADP-ribosylation
superfamily: ADP-ribosylation
family: Poly(ADP-ribose) polymerase, C-terminal domain
domain: Poly(ADP-ribose) polymerase, C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]
 Score =  173 bits (440), Expect = 2e-50
 Identities = 74/220 (33%), Positives = 114/220 (51%), Gaps = 7/220 (3%)

Query: 589 LACSISALEKDSDDYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNA-QPSLDEIKK 647
           L   I  ++KDS++ K+I  Y++ T+         Y + V  IF IE           K+
Sbjct: 1   LRTDIKVVDKDSEEAKIIKQYVKNTHAATH---NAYDLKVVEIFRIEREGESQRYKPFKQ 57

Query: 648 LPNKVLLWCGTRSSNLLRHLQKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAAD 707
           L N+ LLW G+R++N    L +G   A    PV GYMFG+ I  +D  +++A Y  T+  
Sbjct: 58  LHNRQLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQA 117

Query: 708 RPEGFLVLAVASLGDQVTELKKPPEDTKSLEDKKLGVKGLGRKKTDESEHFFWNDDIKVP 767
            P G ++L   +LG+ + ELK     TK L   K  VKGLG+   D +      D ++VP
Sbjct: 118 DPIGLILLGEVALGN-MYELKNASHITK-LPKGKHSVKGLGKTAPDPTATTTL-DGVEVP 174

Query: 768 GGRLIPSEHKNSPLEYNEYAVYDPKQTSIRFLVGVKFEER 807
            G  I +   ++ L YNEY VYD  Q ++++L+ +KF  +
Sbjct: 175 LGNGISTGINDTCLLYNEYIVYDVAQVNLKYLLKLKFNYK 214


>d1gs0a2 d.166.1.2 (A:341-557) Poly(ADP-ribose) polymerase, C-terminal domain {Mouse (Mus musculus) [TaxId: 10090]} Length = 217 Back     information, alignment and structure
>d1efya1 a.41.1.1 (A:662-796) Domain of poly(ADP-ribose) polymerase {Chicken (Gallus gallus) [TaxId: 9031]} Length = 135 Back     information, alignment and structure
>d1gs0a1 a.41.1.1 (A:207-340) Domain of poly(ADP-ribose) polymerase {Mouse (Mus musculus) [TaxId: 10090]} Length = 134 Back     information, alignment and structure
>d2cr9a1 d.297.1.1 (A:8-133) Poly [ADP-ribose] polymerase-1, PARP-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 126 Back     information, alignment and structure
>d1l7ba_ c.15.1.2 (A:) NAD+-dependent DNA ligase, domain 4 {Thermus thermophilus [TaxId: 274]} Length = 92 Back     information, alignment and structure
>d1kzyc1 c.15.1.4 (C:1714-1866) 53BP1 {Human (Homo sapiens) [TaxId: 9606]} Length = 153 Back     information, alignment and structure
>d1t15a2 c.15.1.3 (A:1758-1859) Breast cancer associated protein, BRCA1 {Human (Homo sapiens) [TaxId: 9606]} Length = 102 Back     information, alignment and structure
>d1wf6a_ c.15.1.5 (A:) DNA topoisomerase II binding protein 1, TopBP1 {Human (Homo sapiens) [TaxId: 9606]} Length = 132 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query815
d1gs0a2217 Poly(ADP-ribose) polymerase, C-terminal domain {Mo 100.0
d1efya2215 Poly(ADP-ribose) polymerase, C-terminal domain {Ch 100.0
d2cr9a1126 Poly [ADP-ribose] polymerase-1, PARP-1 {Human (Hom 100.0
d1efya1135 Domain of poly(ADP-ribose) polymerase {Chicken (Ga 100.0
d1gs0a1134 Domain of poly(ADP-ribose) polymerase {Mouse (Mus 100.0
d1l7ba_92 NAD+-dependent DNA ligase, domain 4 {Thermus therm 99.5
d1cdza_96 DNA-repair protein XRCC1 {Human (Homo sapiens) [Ta 99.29
d1t15a2102 Breast cancer associated protein, BRCA1 {Human (Ho 99.28
d1wf6a_132 DNA topoisomerase II binding protein 1, TopBP1 {Hu 99.27
d1t15a1109 Breast cancer associated protein, BRCA1 {Human (Ho 99.16
d1kzyc1153 53BP1 {Human (Homo sapiens) [TaxId: 9606]} 98.48
d1in1a_88 DNA ligase III alpha {Human (Homo sapiens) [TaxId: 98.45
d1l0ba297 Breast cancer associated protein, BRCA1 {Rat (Ratt 97.36
d1kzyc2106 53BP1 {Human (Homo sapiens) [TaxId: 9606]} 97.36
d1jeqa151 DNA binding C-terminal domain of ku70 {Human (Homo 85.43
d1zrja137 Heterogeneous nuclear ribonucleoprotein U-like pro 83.62
d1h1js_44 S/mar DNA-binding protein Tho1 {Baker's yeast (Sac 82.78
>d1gs0a2 d.166.1.2 (A:341-557) Poly(ADP-ribose) polymerase, C-terminal domain {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
class: Alpha and beta proteins (a+b)
fold: ADP-ribosylation
superfamily: ADP-ribosylation
family: Poly(ADP-ribose) polymerase, C-terminal domain
domain: Poly(ADP-ribose) polymerase, C-terminal domain
species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00  E-value=2e-55  Score=452.08  Aligned_cols=212  Identities=30%  Similarity=0.595  Sum_probs=199.7

Q ss_pred             cCceeEEcCCCCHHHHHHHHHHHhccCCCccCCcccccccceeeeEecCC-ccchhhhhcCCCceeeeccCCccchhhhc
Q 037230          589 LACSISALEKDSDDYKMIVNYLEKTYEPVKLGDIEYGVSVDNIFVIESNA-QPSLDEIKKLPNKVLLWCGTRSSNLLRHL  667 (815)
Q Consensus       589 L~~~i~~L~~~s~ey~~I~~y~~~t~~~~h~~~~~~~~~I~~If~v~r~~-~~~f~~~~~~~N~~lLwHGSr~~N~~gIL  667 (815)
                      |+|+|+||+++|+||++|.+||.+|++++|   ..+.++|++||+|+|.+ +++|.  .+.+|+++|||||+.+|+.+||
T Consensus         1 L~c~i~~l~~~s~ey~~I~~~~~~t~~~~~---~~~~~~I~~I~~v~r~~e~~~~~--~~~~n~~~LfHGT~~~n~~~Il   75 (217)
T d1gs0a2           1 LHCALRPLDHESNEFKVISQYLQSTHAPTH---KDYTMTLLDVFEVEKEGEKEAFR--EDLPNRMLLWHGSRLSNWVGIL   75 (217)
T ss_dssp             TTEEEEECCTTSHHHHHHHHHHHHTCCTTC---CSEEEEEEEEEEEEETTHHHHSC--TTCSCEEEEEEEECGGGHHHHH
T ss_pred             CCCEEEEcCCCCHHHHHHHHHHHhhCCCcc---CCCcceEEEEEEEcchhHHHHhh--hcCCceEEEEecccHHHHHHHH
Confidence            799999999999999999999999999988   67889999999999999 99997  5789999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCceeeeeeeechhhhhhhcccccCCCCCceEEEEEEEecCCcceeccCCCCcCccCCCCCcceeee
Q 037230          668 QKGFLPASCSLPVPGYMFGRAIVCSDAAAEAARYGFTAADRPEGFLVLAVASLGDQVTELKKPPEDTKSLEDKKLGVKGL  747 (815)
Q Consensus       668 ~~Gl~iap~~a~~tG~mFGkGIYFAd~~skS~~Yc~~~~~~~~~~mlLceVaLG~~~~e~~~~~~~~~~~p~G~~Sv~g~  747 (815)
                      ++||+++++.++.+|+|||+||||||++|+|++||+++.+++.++||||+||||+ +.+++..+..+.+||+|+|||+|+
T Consensus        76 ~~Gf~~~~~~~~~~g~~fG~GiYfa~~~s~s~~y~~~~~~~~~~~m~l~~V~lG~-~~~~~~~~~~~~~~p~g~~sv~~~  154 (217)
T d1gs0a2          76 SHGLRVAPPEAPITGYMFGKGIYFADMSSKSANYCFASRLKNTGLLLLSEVALGQ-CNELLEANPKAQGLLRGKHSTKGM  154 (217)
T ss_dssp             HHCSCCCCSSSCGGGSTTSSSEEEBSCHHHHHGGGCCCSSSCEEEEEEEEEECCS-EEEESSCCTTGGGGCTTCSEEEEC
T ss_pred             HcCCCCCCccCcccceeeeccceeccccccccccccCCcCCCeEEEEEEEEEecc-eeeeccCCcccccCCCCcceeeec
Confidence            9999999999999999999999999999999999999888899999999999999 888888878899999999999999


Q ss_pred             ccccCCCCCceeecCCeEecCCCcccCCC---CCCCCCCceEEEecCCCcceeeEEEEEeccc
Q 037230          748 GRKKTDESEHFFWNDDIKVPGGRLIPSEH---KNSPLEYNEYAVYDPKQTSIRFLVGVKFEER  807 (815)
Q Consensus       748 G~~~Pdp~~~~~~~dgv~vP~G~~~~~~~---~~~~l~ynEyIVYd~~Qv~~rYLv~~~~~~~  807 (815)
                      |++.|+|+..+.+ ||+.||+|+.+++..   .+.+|.||||||||++||+|||||+|+|+|+
T Consensus       155 g~~~p~p~~~~~~-~g~~vp~g~~~~s~~~~~~~~~l~~nEyVVy~~~Qv~~~YLi~~k~~~~  216 (217)
T d1gs0a2         155 GKMAPSPAHFITL-NGSTVPLGPASDTGILNPEGYTLNYNEFIVYSPNQVRMRYLLKIQFNFL  216 (217)
T ss_dssp             CSEECCGGGCEEE-TTEEECCSCCEECCCCCSSSCCCSBCEEEESCGGGEEEEEEEEEEEEEC
T ss_pred             ccccCChhhcccc-CCeeccCCCccccCccCCCCCccccCeEEEEchhheeEEEEEEEEEEec
Confidence            9999999988776 999999999886543   3567999999999999999999999999986



>d1efya2 d.166.1.2 (A:797-1011) Poly(ADP-ribose) polymerase, C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d2cr9a1 d.297.1.1 (A:8-133) Poly [ADP-ribose] polymerase-1, PARP-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1efya1 a.41.1.1 (A:662-796) Domain of poly(ADP-ribose) polymerase {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1gs0a1 a.41.1.1 (A:207-340) Domain of poly(ADP-ribose) polymerase {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1l7ba_ c.15.1.2 (A:) NAD+-dependent DNA ligase, domain 4 {Thermus thermophilus [TaxId: 274]} Back     information, alignment and structure
>d1cdza_ c.15.1.1 (A:) DNA-repair protein XRCC1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1t15a2 c.15.1.3 (A:1758-1859) Breast cancer associated protein, BRCA1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1wf6a_ c.15.1.5 (A:) DNA topoisomerase II binding protein 1, TopBP1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1t15a1 c.15.1.3 (A:1649-1757) Breast cancer associated protein, BRCA1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1kzyc1 c.15.1.4 (C:1714-1866) 53BP1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1in1a_ c.15.1.2 (A:) DNA ligase III alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1l0ba2 c.15.1.3 (A:1705-1801) Breast cancer associated protein, BRCA1 {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1kzyc2 c.15.1.4 (C:1867-1972) 53BP1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1jeqa1 a.140.2.1 (A:559-609) DNA binding C-terminal domain of ku70 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1zrja1 a.140.2.1 (A:1-37) Heterogeneous nuclear ribonucleoprotein U-like protein 1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h1js_ a.140.2.1 (S:) S/mar DNA-binding protein Tho1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Back     information, alignment and structure